<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants - Green, DS - 2019 | Cochrane Library</title> <meta content="Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants - Green, DS - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011785.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants - Green, DS - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011785.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011785.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants" name="citation_title"/> <meta content="Daniel Stephen Green" name="citation_author"/> <meta content="Mohamed E Abdel‐Latif" name="citation_author"/> <meta content="Abdel-Latif.Mohamed@act.gov.au" name="citation_author_email"/> <meta content="Lisa J Jones" name="citation_author"/> <meta content="University of Sydney" name="citation_author_institution"/> <meta content="Kei Lui" name="citation_author"/> <meta content="David A Osborn" name="citation_author"/> <meta content="Central Clinical School, School of Medicine, The University of Sydney" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD011785.pub2" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/07/02" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011785.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011785.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011785.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti‐Ulcer Agents [therapeutic use]; Enterocolitis, Necrotizing [prevention &amp; control]; Gastrointestinal Hemorrhage [*drug therapy, *prevention &amp; control]; Histamine H2 Antagonists [therapeutic use]; Proton Pump Inhibitors [therapeutic use]; Randomized Controlled Trials as Topic; Sucralfate [therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011785.pub2&amp;doi=10.1002/14651858.CD011785.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="zCmos3jT";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011785\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011785\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011785\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011785\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ru","ms","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011785.pub2",title:"Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants",firstPublishedDate:"Jul 2, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neonatal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=zCmos3jT&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011785.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011785.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011785.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011785.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011785.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011785.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011785.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011785.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011785.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011785.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5359 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011785.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/full#CD011785-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/full#CD011785-sec-0105"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/full#CD011785-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/full#CD011785-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/full#CD011785-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/full#CD011785-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/full#CD011785-sec-0066"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/full#CD011785-sec-0097"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/appendices#CD011785-sec-0110"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/table_n/CD011785StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/table_n/CD011785StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/information#CD011785-cr-0002">Daniel Stephen Green</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/information#CD011785-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>Mohamed E Abdel‐Latif</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/information#CD011785-cr-0004">Lisa J Jones</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/information#CD011785-cr-0005">Kei Lui</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011785.pub2/information#CD011785-cr-0006">David A Osborn</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/information/en#CD011785-sec-0114">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 02 July 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011785.pub2">https://doi.org/10.1002/14651858.CD011785.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011785-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011785-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011785-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011785-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011785-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011785-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011785-abs-0001" lang="en"> <section id="CD011785-sec-0001"> <h3 class="title" id="CD011785-sec-0001">Background</h3> <p>Upper gastrointestinal bleeding is typically a mild, self‐limiting condition that can affect both preterm and term neonates, although it can be severe particularly when associated with co‐morbidities. Pharmacological interventions with a proton pump inhibitor (PPI), H2 receptor antagonist (H2RA), antacid, bismuth and sucralfate may have effects on both the prevention and treatment of upper gastrointestinal bleeding in infants. </p> </section> <section id="CD011785-sec-0002"> <h3 class="title" id="CD011785-sec-0002">Objectives</h3> <p>To assess how different pharmacological interventions (PPIs, H2RAs, antacids, sucralfate or bismuth salts) administered to preterm and term neonates for the prevention or treatment of upper gastrointestinal bleeding to reduce morbidity and mortality compare with placebo or no treatment, supportive care, or each other. </p> </section> <section id="CD011785-sec-0003"> <h3 class="title" id="CD011785-sec-0003">Search methods</h3> <p>We used the standard search strategy of Cochrane Neonatal to search the Cochrane Central Register of Controlled Trials (CENTRAL 2018, Issue 6), MEDLINE via PubMed (1966 to 12 July 2018), Embase (1980 to 12 July 2018), and CINAHL (1982 to 12 July 2018). We also searched clinical trial databases, conference proceedings, the reference lists of retrieved articles for randomised controlled trials and quasi‐randomised trials, and online for Chinese literature articles<b>.</b> </p> </section> <section id="CD011785-sec-0004"> <h3 class="title" id="CD011785-sec-0004">Selection criteria</h3> <p>We selected randomised, quasi‐randomised and cluster‐randomised trials involving preterm and term neonates. Trials were included if they used a proton pump inhibitor, H2 receptor antagonist, antacid, sucralfate or bismuth either for the prevention or treatment of upper gastrointestinal bleeding. </p> </section> <section id="CD011785-sec-0005"> <h3 class="title" id="CD011785-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed the eligibility of studies for inclusion, extracted data and assessed methodological quality. We conducted meta‐analysis using a fixed‐effect model. We used the GRADE approach to assess quality of evidence. </p> </section> <section id="CD011785-sec-0006"> <h3 class="title" id="CD011785-sec-0006">Main results</h3> <p>Eleven studies with 818 infants met the criteria for inclusion in this review.</p> <p>Four trials with 329 infants assessed the use of an H2 receptor antagonist for prevention of upper gastrointestinal bleeding in high‐risk newborn infants. Meta‐analysis of these four trials identified a reduction in any upper gastrointestinal bleeding when using an H2 receptor antagonist (typical risk ratio (RR) 0.36, 95% confidence interval (CI) 0.22 to 0.58; typical risk difference (RD) −0.20, 95% CI −0.28 to −0.11; number needed to treat for an additional beneficial outcome (NNTB) 5, 95% CI 4 to 9). The quality of evidence was moderate. A single trial with 53 infants assessing prevention of upper gastrointestinal bleeding reported no difference in mortality in infants assigned H2 receptor antagonist versus no treatment; however the quality of evidence was very low. </p> <p>Seven trials with 489 infants assessed an inhibitor of gastric acid (H2 receptor antagonist or proton pump inhibitor) for treatment of gastrointestinal bleeding in newborn infants. Meta‐analysis of two trials (131 infants) showed no difference in mortality from use of a H2 receptor antagonist compared to no treatment. The quality of evidence was low. Meta‐analysis of two trials (104 infants) showed a reduction in duration of upper gastrointestinal bleeding from use of an inhibitor of gastric acid compared to no treatment (mean difference −1.06 days, 95% CI −1.28 to −0.84). The quality of evidence was very low. Meta‐analysis of six trials (451 infants) showed a reduction in continued upper gastrointestinal bleeding from use of any inhibitor of gastric acid compared to no treatment (typical RR 0.36, 95% CI 0.26 to 0.49; typical RD −0.26, 95% CI −0.33, −0.19; NNTB 4, 95% CI 3 to 5). The quality of evidence was low. There were no significant subgroup differences in duration of upper gastrointestinal bleeding or of continued upper gastrointestinal bleeding according to type of inhibitor of gastric acid. A single trial (38 infants) reported no difference in anaemia requiring blood transfusion from use of a H2 receptor antagonist compared to no treatment. </p> <p>Although no serious adverse events were reported from the use of a H2 receptor antagonist or proton pump inhibitor, some neonatal morbidities — including necrotising enterocolitis, ventilator‐associated pneumonia, duration of ventilation and respiratory support, and duration of hospital stay — were not reported. Long‐term outcome was not reported. </p> </section> <section id="CD011785-sec-0007"> <h3 class="title" id="CD011785-sec-0007">Authors' conclusions</h3> <p>There is moderate‐quality evidence that use of an H2 receptor antagonist reduces the risk of gastrointestinal bleeding in newborn infants at high risk of gastrointestinal bleeding. There is low‐quality evidence that use of an inhibitor of gastric acid (H2 receptor antagonist or proton pump inhibitor) reduces the duration of upper gastrointestinal bleeding and the incidence of continued gastric bleeding in newborn infants with gastrointestinal bleeding. However, there is no evidence that use of an inhibitor of gastric acid in newborn infants affects mortality or the need for blood transfusion. As no study reported the incidence of necrotising enterocolitis, ventilator‐ or hospital‐associated pneumonia, sepsis, or long‐term outcome, the safety of inhibitors of gastric acid secretion is unclear. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011785-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011785-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011785-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011785-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011785-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011785-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD011785-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011785-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011785-abs-0005" lang="en"> <h3>Pharmacological interventions to prevent and treat upper gastrointestinal bleeding in neonates </h3> <p><b>Review question</b><br/> To assess how different medications for reducing stomach acidity (proton pump inhibitors, histamine 2 receptor antagonists, antacids) or for protecting the stomach lining (sucralfate or bismuth salts) given to preterm and term infants help to prevent or treat upper gastrointestinal bleeding, reduce suffering of other illnesses and deaths. </p> <p><b>Background</b><br/> Upper gastrointestinal bleeding is common in sick newborns admitted to neonatal intensive care. It may be associated with reflux of milk (gastroesophageal reflux) or allergy to milk proteins. Common symptoms include vomiting of material which can be either bloodstained or like coffee grounds in appearance; and black, tarry stools. When occurring in otherwise well newborns it is typically a mild, self‐limiting condition. However, upper gastrointestinal bleeding can be severe particularly when associated with other underlying conditions. </p> <p><b>Study characteristics</b><br/> We included randomised controlled trials (RCTs). The search is up to date as of 12 July 2018. </p> <p><b>Key results</b><br/> We found 11 trials with 818 infants. We considered no trial to be at low risk of bias. </p> <p>Four trials included 329 infants in neonatal intensive care units and used a histamine 2 receptor antagonist for prevention of upper gastrointestinal bleeding. These four trials demonstrated a reduction in the incidence of upper gastrointestinal bleeding with a histamine 2 receptor antagonist, but no change in mortality. Outcomes such as serious gastrointestinal problems (e.g. necrotising enterocolitis) and infections were not reported. </p> <p>Seven trials with 489 infants enrolled sick newborn infants with upper gastrointestinal bleeding and used either a histamine 2 receptor antagonist or a proton pump inhibitor for treatment. Use of a histamine 2 receptor antagonist or proton pump inhibitor in a treatment context was associated with a reduction of both duration of upper gastrointestinal bleeding and continued upper gastrointestinal bleeding; however it did not affect mortality or requirement for blood transfusion. No long‐term follow‐up was reported. </p> <p>Although there is moderate‐quality evidence that use of an inhibitor of gastric acid reduces the incidence and duration of upper gastrointestinal bleeding in newborn infants, there is insufficient safety data in this population. The implication of this is that caution should be applied when deciding whether to use an inhibitor of gastric acid in sick newborn infants until additional studies are performed. </p> <p><b>Quality of the evidence</b><br/> We graded the quality of evidence for prevention of upper gastrointestinal bleeding as low and moderate. We graded the quality of evidence for the treatment of upper gastrointestinal bleeding as low and very low. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011785-sec-0105" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011785-sec-0105"></div> <h3 class="title" id="CD011785-sec-0106">Implications for practice</h3> <section id="CD011785-sec-0106"> <p>There is moderate‐quality evidence that the use of a histamine 2 receptor antagonist (H2RA) reduces the risk of gastrointestinal bleeding in newborn infants at high risk of gastrointestinal bleeding. There is low‐quality evidence that use of an inhibitor of gastric acid (H2RA or proton pump inhibitor) reduces the duration of upper gastrointestinal bleeding and reduces the incidence of continued gastric bleeding in newborn infants with gastrointestinal bleeding. However, there is no evidence that use of an inhibitor of gastric acid in newborn infants affects mortality or the need for blood transfusion. As no study reported the incidence of necrotising enterocolitis, ventilator‐ or hospital‐associated pneumonia, sepsis, or long‐term outcome, the safety of inhibitors of gastric acid secretion remains unclear. There is no evidence that there is additional benefit from use of a higher dose of an H2RA or a proton pump inhibitor for prevention or treatment of gastrointestinal bleeding in newborn infants. </p> </section> <h3 class="title" id="CD011785-sec-0107">Implications for research</h3> <section id="CD011785-sec-0107"> <p>Further trials of the use of an inhibitor of gastric acid (H2RA or PPI) in newborn infants are required to determine if the clinical effectiveness in reducing gastrointestinal bleeding and duration outweighs the potential harms. Trials should report and be powered to detect clinically important effects of the rate of necrotising enterocolitis in preterm infants, ventilator‐ and hospital‐acquired infection, and sepsis. Trials comparing the use of H2RA versus a PPI, and use of intravenous versus intragastric administration of medication are needed. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011785-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011785-sec-0029"></div> <div class="table" id="CD011785-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Prevention of upper gastrointestinal bleeding in newborn infants</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Prevention of upper gastrointestinal bleeding in newborn infants</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> newborn infants at risk of gastrointestinal bleeding<br/> <b>Settings:</b> neonatal intensive care<br/> <b>Intervention:</b> H2RA versus no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Prevention of upper gastrointestinal bleeding</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>111 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>269 per 1000</b><br/> (78 to 931) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.42</b> <br/> (0.7 to 8.38) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single small study comparing ranitidine versus no treatment.</p> <p>Quality of evidence downgraded due to risk of bias and very serious imprecision.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Any upper gastrointestinal bleeding in infants at risk of upper gastrointestinal bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>305 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>110 per 1000</b><br/> (67 to 177) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.36</b> <br/> (0.22 to 0.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>329<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All studies compared H2RA versus no treatment.</p> <p>Quality of evidence downgraded due to risk of bias.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> No study at low risk of bias.<br/> <sup>2</sup> Single small study. Very wide confidence intervals. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011785-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Treatment of upper gastrointestinal bleeding in newborn infants</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Treatment of upper gastrointestinal bleeding in newborn infants</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> infants with upper gastrointestinal bleeding<br/> <b>Settings:</b> neonatal intensive care<br/> <b>Intervention:</b> inhibitor of gastric acid (H2RA and PPIs) versus no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Treatment of upper gastrointestinal bleeding</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>169 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>107 per 1000</b><br/> (44 to 256) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.63</b> <br/> (0.26 to 1.51) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>131<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Both studies compared H2RA versus no treatment.</p> <p>Quality of evidence downgraded due to risk of bias and imprecision.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Duration of upper gastrointestinal bleeding (days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1.06 lower</b><br/> (1.28 to 0.84 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>104<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 study compared PPI versus no treatment. 1 study compared H2RA versus no treatment. No significant subgroup difference. </p> <p>Quality of evidence downgraded due to risk of bias, inconsistency and imprecision.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Continued upper gastrointestinal bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>400 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>144 per 1000</b><br/> (104 to 196) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.36</b> <br/> (0.26 to 0.49) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>451<br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 studies compared PPI versus no treatment. 3 studies compared H2RA versus no treatment. No significant subgroup difference. </p> <p>Quality of evidence downgraded due to risk of bias and imprecision.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Anaemia requiring blood transfusion</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>167 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>100 per 1000</b><br/> (18 to 532) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.6</b> <br/> (0.11 to 3.19) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single small study comparing ranitidine versus no treatment.</p> <p>Quality of evidence downgraded due to risk of bias and imprecision.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> No study at low risk of bias.<br/> <sup>2</sup> Wide confidence intervals. <br/> <sup>3</sup> Moderate heterogeneity between studies. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011785-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011785-sec-0030"></div> <section id="CD011785-sec-0031"> <h3 class="title" id="CD011785-sec-0031">Description of the condition</h3> <p>Upper gastrointestinal bleeding (arising proximal to the ligament of Treitz in the distal duodenum) is typically a mild, self‐limiting condition that can affect both preterm and term neonates. Common signs of upper gastrointestinal bleeding include vomiting of bloodstained material or material with the appearance of coffee grounds (haematemesis); and black, tarry stools (melena) (<a href="./references#CD011785-bbs2-0074" title="GreenBT , RockeyDC . Acute gastrointestinal bleeding. Seminars in Gastrointestinal Disease2003;14(2):44‐65. [PUBMED: 12889580] ">Green 2003</a>). Upper gastrointestinal bleeding can be diagnosed clinically by the presence of blood‐stained aspirates through indwelling nasogastric or orogastric tubes; haematemesis; or endoscopically by examining the gastric mucosa for bleeding lesions (<a href="./references#CD011785-bbs2-0074" title="GreenBT , RockeyDC . Acute gastrointestinal bleeding. Seminars in Gastrointestinal Disease2003;14(2):44‐65. [PUBMED: 12889580] ">Green 2003</a>). It is important to differentiate newborn infants who have swallowed maternal blood from those with gastric bleeding (<a href="./references#CD011785-bbs2-0059" title="AptL , DowneyWSJr . Melena neonatorum: the swallowed blood syndrome; a simple test for the differentiation of adult and fetal hemoglobin in bloody stools. Journal of Pediatrics1955;47(1):6‐12. [PUBMED: 14392548] ">Apt 1955</a>). Severe gastrointestinal bleeding occurs in newborn infants but is more common in older infant patient populations (<a href="./references#CD011785-bbs2-0096" title="RomanoC , OlivaS , MartellossiS , MieleE , ArrigoS , GrazianiMG , CardileS , GaianiF , de'AngelisGL , TorroniF . Pediatric gastrointestinal bleeding: Perspectives from the Italian Society of Pediatric Gastroenterology. World Journal of Gastroenterology2017;23:1328‐37. ">Romano 2017</a>). A bleeding associated mortality rate of 2.07% has been reported in children admitted with gastrointestinal bleeding in the USA (<a href="./references#CD011785-bbs2-0062" title="AttardTM , MillerM , PantC , KumarA , ThomsonM . Mortality associated with gastrointestinal bleeding in children: A retrospective cohort study. World Journal of Gastroenterology2017;23:1608‐17. ">Attard 2017</a>). Mortalities were significantly more likely to have multiple complex chronic conditions compared to children with a principle diagnosis of gastrointestinal bleeding with a mortality of 0.37%. However, the outcomes of newborns with upper gastrointestinal bleeding have not been similarly reported. </p> <p>Reported causes of gastrointestinal bleeding in newborns include coagulation disorders, such as vitamin K deficiency, cow’s milk protein allergy, stress‐related gastritis, sepsis, and trauma from placement of nasogastric tubes (<a href="./references#CD011785-bbs2-0066" title="BoyleJT . Gastrointestinal bleeding in infants and children. Pediatrics in Review2008;29(2):39‐52. [DOI: 10.1542/pir.29‐2‐39; PUBMED: 18245300] ">Boyle 2008</a>; <a href="./references#CD011785-bbs2-0068" title="ChawlaS , SethD , MahajanP , KamatD . Upper gastrointestinal bleeding in children. Clinical Pediatrics2007;46(1):16‐21. [DOI: 10.1177/1084713806297151; PUBMED: 17164504] ">Chawla 2007</a>; <a href="./references#CD011785-bbs2-0096" title="RomanoC , OlivaS , MartellossiS , MieleE , ArrigoS , GrazianiMG , CardileS , GaianiF , de'AngelisGL , TorroniF . Pediatric gastrointestinal bleeding: Perspectives from the Italian Society of Pediatric Gastroenterology. World Journal of Gastroenterology2017;23:1328‐37. ">Romano 2017</a>). However population data on the incidence and causes in newborns are limited. <a href="./references#CD011785-bbs2-0083" title="LazzaroniM , PetrilloM , TornaghiR , MassironiE , SainaghiM , PrincipiN , et al. Upper GI bleeding in healthy full‐term infants: a case‐control study. American Journal of Gastroenterology2002;97(1):89‐94. [DOI: 10.1111/j.1572‐0241.2002.05443.x; PUBMED: 11808975] ">Lazzaroni 2002</a> reported 64 of 5180 newborn babies (1.23%) suffered from upper gastrointestinal bleeding. Endoscopy revealed oesophageal damage in 24/53 infants, gastric and duodenal lesions in 43/52 and 1/52 infants, respectively. No maternal or newborn infant clinical risk factors were identified between cases and controls. A retrospective study undertaken by <a href="./references#CD011785-bbs2-0080" title="KuuselaAL , MäkiM , RuuskaT , LaippalaP . Stress‐induced gastric findings in critically ill newborn infants: frequency and risk factors. Intensive Care Medicine2000;26(10):1501‐6. [PUBMED: 11126263] ">Kuusela 2000</a> reported approximately 20% of infants treated in a neonatal intensive care unit had signs of gastrointestinal bleeding, with mechanical ventilation the major risk factor. In mechanically ventilated infants, 53% had gastric mucosal lesions. Risk factors for mucosal lesions included interventional delivery, delayed delivery and hypotension after birth. </p> </section> <section id="CD011785-sec-0032"> <h3 class="title" id="CD011785-sec-0032">Description of the intervention</h3> <p>Acid suppression agents are used in the management of upper gastrointestinal bleeding in the adult population (<a href="./references#CD011785-bbs2-0091" title="MejiaA , KraftWK . Acid peptic diseases: pharmacological approach to treatment. Expert Review of Clinical Pharmacology2009;2(3):295‐314. [DOI: 10.1586/ecp.09.8; PUBMED: 21822447] ">Mejia 2009</a>). However, evidence‐based recommendations supporting similar benefits for newborn infants are not readily available. The main principle underlying pharmacological intervention is to protect the gastric mucosa from damage and promote healing. In adults with peptic ulcers, gastric acidity has been associated with ongoing mucosal tissue damage and reduced clot formation (<a href="./references#CD011785-bbs2-0078" title="KolkmanJJ , MeuwissenSG . A review on treatment of bleeding peptic ulcer: a collaborative task of gastroenterologist and surgeon. Scandinavian Journal of Gastroenterology1996;218:16‐25. [PUBMED: 8865446] ">Kolkman 1996</a>). Individuals with gastric ulcers and a gastric acidity of pH less than 6 are predisposed to increased fibrinolysis of overlying clots (<a href="./references#CD011785-bbs2-0073" title="GreenFWJr , KaplanMM , CurtisLE , LevinePH . Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology1978;74(1):38‐43. [PUBMED: 21830] ">Green 1978</a>). Although the role of acid in the aetiology of gastric lesions in adults has been described, its role is unclear in neonates (<a href="./references#CD011785-bbs2-0087" title="MakiM , RuuskaT , KuuselaAL , Karikoski‐LeoR , IkonenRS . High prevalence of asymptomatic esophageal and gastric lesions in preterm infants in intensive care. Critical care medicine1993;21(12):1863‐7. [PUBMED: 8252891] ">Maki 1993</a>). </p> <p>Drugs commonly used to treat conditions associated with upper gastrointestinal bleeding include the following. </p> <p> <ol id="CD011785-list-0001"> <li> <p>Proton pump inhibitors (PPIs) ‒ acid suppressors (e.g. omeprazole).</p> </li> <li> <p>H2 receptor antagonists (H2RAs) ‒ acid suppressors (e.g. ranitidine, cimetidine and famotidine). </p> </li> <li> <p>Antacids ‒ acid neutralisers (e.g. sodium/calcium carbonate, magnesium/aluminium hydroxide and almagate). </p> </li> <li> <p>Mucosal protective agents (e.g. sucralfate and bismuth salts).</p> </li> </ol> </p> <p>PPIs, such as omeprazole, are prodrugs that require protonation to exert their inhibitory effect on H<sup>+</sup>‐K<sup>+</sup>‐ATPase. This results in decreased gastric acid production (<a href="./references#CD011785-bbs2-0097" title="SachsG , ShinJM , VaginO , LambrechtN , YakubovI , MunsonK . The gastric H,K ATPase as a drug target: past, present, and future. Journal of Clinical Gastroenterology2007;41 Suppl 2:S226‐42. [DOI: 10.1097/MCG.0b013e31803233b7; PUBMED: 17575528] ">Sachs 2007</a>). PPIs further protect the mucosal lining of the stomach by reducing pepsin secretion (<a href="./references#CD011785-bbs2-0067" title="BrunnerG , HellM , HengelsKJ , HennigU , FuchsW . Influence of lansoprazole on intragastric 24‐hour pH, meal‐stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers. Digestion1995;56(2):137‐44. [DOI: 10.1159/000201233; PUBMED: 7750667] ">Brunner 1995</a>). H2RAs, such as ranitidine, also act to suppress gastric acid production. They achieve this through binding to H2 receptors on the basolateral side of parietal cells, which results in inhibition of the effects of histamine. H2RAs have a faster onset of action but shorter duration of action compared to PPIs (<a href="./references#CD011785-bbs2-0063" title="Australian MedicinesHandbook . Australian Medicines Handbook. Adelaide (AU): Newstyle Printing, 2013. ">Australian Medicines Handbook 2013</a>). </p> <p>Significant adverse effects of PPIs and H2RAs are infrequent or rare and include hypotension, rashes, thrombocytopaenia and insomnia (<a href="./references#CD011785-bbs2-0063" title="Australian MedicinesHandbook . Australian Medicines Handbook. Adelaide (AU): Newstyle Printing, 2013. ">Australian Medicines Handbook 2013</a>). H2RAs have been associated with an increased risk of necrotizing enterocolitis (NEC) in very low birth weight (VLBW) infants (<a href="./references#CD011785-bbs2-0092" title="MoreK , Athalye‐JapeG , RaoS , PatoleS . Association of inhibitors of gastric acid secretion and higher incidence of necrotizing enterocolitis in preterm very low‐birth‐weight infants. American Journal of Perinatology2013;30(10):849‐56. [DOI: 10.1055/s‐0033‐1333671; PUBMED: 23359235] ">More 2013</a>; <a href="./references#CD011785-bbs2-0048" title="TerrinG , PassarielloA , DeCurtisM , MangusoF , SalviaG , LegaL , et al. Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns. Pediatrics2012;129(1):e40‐5. [DOI: 10.1542/peds.2011‐0796; PUBMED: 22157140] ">Terrin 2012</a>). In mechanically ventilated patients, PPIs were associated with an increased risk of gastrointestinal haemorrhage, pneumonia and <i>Clostridium difficile</i> infection compared to patients administered H2RAs (<a href="./references#CD011785-bbs2-0086" title="MacLarenR , ReynoldsPM , AllenRR . Histamine‐2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Internal Medicine2014;174(4):564‐74. [DOI: 10.1001/jamainternmed.2013.14673; PUBMED: 24535015] ">MacLaren 2014</a>). </p> <p>Unlike PPIs and H2RAs, antacids exert their effects within the gut lumen. They both neutralise gastric acid and inhibit pepsin activity (<a href="./references#CD011785-bbs2-0090" title="MatonPN , BurtonME . Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use. Drugs1999;57(6):855‐70. [PUBMED: 10400401] ">Maton 1999</a>). Sodium bicarbonate, calcium bicarbonate, magnesium hydroxide, aluminium hydroxide and almagate are examples of antacids (<a href="./references#CD011785-bbs2-0091" title="MejiaA , KraftWK . Acid peptic diseases: pharmacological approach to treatment. Expert Review of Clinical Pharmacology2009;2(3):295‐314. [DOI: 10.1586/ecp.09.8; PUBMED: 21822447] ">Mejia 2009</a>). Possible adverse effects of antacids include hypophosphataemia, hypermagnesaemia, intestinal obstruction and osteomalacia (<a href="./references#CD011785-bbs2-0063" title="Australian MedicinesHandbook . Australian Medicines Handbook. Adelaide (AU): Newstyle Printing, 2013. ">Australian Medicines Handbook 2013</a>). </p> <p>Whilst PPIs, H2RAs and antacids predominantly influence acid secretion, sucralfate and bismuth treatment aims to protect the gastric mucosa (<a href="./references#CD011785-bbs2-0063" title="Australian MedicinesHandbook . Australian Medicines Handbook. Adelaide (AU): Newstyle Printing, 2013. ">Australian Medicines Handbook 2013</a>). Both of these drugs are excreted in faeces (<a href="./references#CD011785-bbs2-0091" title="MejiaA , KraftWK . Acid peptic diseases: pharmacological approach to treatment. Expert Review of Clinical Pharmacology2009;2(3):295‐314. [DOI: 10.1586/ecp.09.8; PUBMED: 21822447] ">Mejia 2009</a>). Sucralfate may cause adverse constipation and nausea, whilst bismuth more commonly causes blackening of faeces and darkening of the teeth and tongue (<a href="./references#CD011785-bbs2-0063" title="Australian MedicinesHandbook . Australian Medicines Handbook. Adelaide (AU): Newstyle Printing, 2013. ">Australian Medicines Handbook 2013</a>). </p> </section> <section id="CD011785-sec-0033"> <h3 class="title" id="CD011785-sec-0033">How the intervention might work</h3> <p>In adult patients, PPIs are indicated for both the prevention and treatment of upper gastrointestinal bleeding (<a href="./references#CD011785-bbs2-0063" title="Australian MedicinesHandbook . Australian Medicines Handbook. Adelaide (AU): Newstyle Printing, 2013. ">Australian Medicines Handbook 2013</a>). Treatment with PPIs has been shown to decrease the rate of re‐bleeding compared to H2RAs or placebo (<a href="./references#CD011785-bbs2-0085" title="LeontiadisGI , HowdenCW . The role of proton pump inhibitors in the management of upper gastrointestinal bleeding. Gastroenterology Clinics of North America2009;38(2):199‐213. [PUBMED: 19446254] ">Leontiadis 2009</a>). This effect has been demonstrated to occur independently of dose, route of administration or geographic location. In adults with upper gastrointestinal bleeding, high‐dose omeprazole infusion has been shown to reduce signs of upper gastrointestinal bleeding and the need for endoscopy therapy (<a href="./references#CD011785-bbs2-0082" title="LauJY , LeungWK , WuJC , ChanFK , WongVW , ChiuPW , et al. Omeprazole before endoscopy in patients with gastrointestinal bleeding. New England Journal of Medicine2007;356(16):1631‐40. [DOI: 10.1056/NEJMoa065703; PUBMED: 17442905] ">Lau 2007</a>). </p> <p>Since gastric acid production is not solely regulated by histamine, H2RAs are not as effective as PPIs at reducing acid production. Consequently, H2RA treatment is no longer recommended for treatment in adult patients with acute ulcer bleeding. However, H2RAs may prove to be useful in treating upper gastrointestinal bleeding in neonates (<a href="./references#CD011785-bbs2-0064" title="BarkunAN , BardouM , KuipersEJ , SungJ , HuntRH , MartelM , et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Annals of Internal Medicine2010;152(2):101‐13. [DOI: 10.7326/0003‐4819‐152‐2‐201001190‐00009; PUBMED: 20083829] ">Barkun 2010</a>). Although PPIs have superior acid suppression ability, the shorter onset of action of H2RAs may provide faster relief of upper gastrointestinal bleeding symptoms (<a href="./references#CD011785-bbs2-0091" title="MejiaA , KraftWK . Acid peptic diseases: pharmacological approach to treatment. Expert Review of Clinical Pharmacology2009;2(3):295‐314. [DOI: 10.1586/ecp.09.8; PUBMED: 21822447] ">Mejia 2009</a>). </p> <p>In adults, antacid use has largely been replaced by PPIs and H2RAs. Despite this, acid neutralisation may have a greater role in the prophylaxis or treatment of upper gastrointestinal bleeding in neonates. </p> <p>In response to the acidic environment of the gut, sucralfate promotes mucosal healing via angiogenesis, growth factor delivery and granulation tissue formation at ulcer sites (<a href="./references#CD011785-bbs2-0102" title="TarnawskiA , TanoueK , SantosAM , SarfehIJ . Cellular and molecular mechanisms of gastric ulcer healing. Is the quality of mucosal scar affected by treatment?. Scandinavian Journal of Gastroenterology1995;210:9‐14. [PUBMED: 8578218] ">Tarnawski 1995</a>). Healing mechanisms of bismuth include stimulating prostaglandin and bicarbonate production in addition to inhibiting the growth of <i>Helicobacter pylori</i> in the gut mucosa (<a href="./references#CD011785-bbs2-0091" title="MejiaA , KraftWK . Acid peptic diseases: pharmacological approach to treatment. Expert Review of Clinical Pharmacology2009;2(3):295‐314. [DOI: 10.1586/ecp.09.8; PUBMED: 21822447] ">Mejia 2009</a>). These mechanisms of mucosal protection may have greater importance in the prophylaxis of upper gastrointestinal bleeding in neonates. </p> <p>The adverse effects associated with acid suppression agents may occur due to several underlying mechanisms. The importance of gastric acid in clearance of ingested pathogens, for example, has been postulated as an underlying pathway in the pathogenesis of NEC in preterm infants (<a href="./references#CD011785-bbs2-0089" title="MartinsenTC , BerghK , WaldumHL . Gastric juice: a barrier against infectious diseases. Basic &amp; Clinical Pharmacology &amp; Toxicology2005;96(2):94‐102. [PUBMED: 15679471] ">Martinsen 2005</a>; <a href="./references#CD011785-bbs2-0092" title="MoreK , Athalye‐JapeG , RaoS , PatoleS . Association of inhibitors of gastric acid secretion and higher incidence of necrotizing enterocolitis in preterm very low‐birth‐weight infants. American Journal of Perinatology2013;30(10):849‐56. [DOI: 10.1055/s‐0033‐1333671; PUBMED: 23359235] ">More 2013</a>; <a href="./references#CD011785-bbs2-0048" title="TerrinG , PassarielloA , DeCurtisM , MangusoF , SalviaG , LegaL , et al. Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns. Pediatrics2012;129(1):e40‐5. [DOI: 10.1542/peds.2011‐0796; PUBMED: 22157140] ">Terrin 2012</a>); and to predispose to ventilator‐associated pneumonia (<a href="./references#CD011785-bbs2-0086" title="MacLarenR , ReynoldsPM , AllenRR . Histamine‐2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Internal Medicine2014;174(4):564‐74. [DOI: 10.1001/jamainternmed.2013.14673; PUBMED: 24535015] ">MacLaren 2014</a>). Inhibiting gastric acid has also been associated with reduced calcium and vitamin B12 absorption, although the significance of this in the neonatal population is unclear (<a href="./references#CD011785-bbs2-0089" title="MartinsenTC , BerghK , WaldumHL . Gastric juice: a barrier against infectious diseases. Basic &amp; Clinical Pharmacology &amp; Toxicology2005;96(2):94‐102. [PUBMED: 15679471] ">Martinsen 2005</a>). As such, acid suppression agents may represent potentially harmful interventions for preterm and term infants. </p> </section> <section id="CD011785-sec-0034"> <h3 class="title" id="CD011785-sec-0034">Why it is important to do this review</h3> <p>Current recommendations for the prevention and treatment of upper gastrointestinal bleeding in neonates are based on those used for adults, largely due to a lack of studies in neonates. International consensus guidelines recommend intravenous and oral PPIs, but not H2RAs, for the prevention and treatment of acute upper gastrointestinal bleeding in adults (<a href="./references#CD011785-bbs2-0064" title="BarkunAN , BardouM , KuipersEJ , SungJ , HuntRH , MartelM , et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Annals of Internal Medicine2010;152(2):101‐13. [DOI: 10.7326/0003‐4819‐152‐2‐201001190‐00009; PUBMED: 20083829] ">Barkun 2010</a>). However, a recent study by <a href="./references#CD011785-bbs2-0101" title="SreedharanA , MartinJ , LeontiadisGI , DorwardS , HowdenCW , FormanD , et al. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database of Systematic Reviews2010, Issue 7. [DOI: 10.1002/14651858.CD005415.pub3; PUBMED: 20614440] ">Sreedharan 2010</a> demonstrated the usefulness of treatment with PPIs in reducing stigmata of recent haemorrhage but not in reducing mortality and re‐bleeding rates. A previous Cochrane Review described benefits of PPI treatment for acute upper gastrointestinal bleeding in adults, but not in neonates (<a href="./references#CD011785-bbs2-0084" title="LeontiadisGI , SharmaVK , HowdenCW . Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD002094.pub3; PUBMED: 15266462] ">Leontiadis 2006</a>). A Cochrane Review reported moderate evidence was found to support the use of PPIs, along with some evidence to support the use of H2RAs in children with gastroesophageal reflux disease (GORD), based on improvement in symptom scores, pH indices and endoscopic/histological appearances; however, no robust RCT evidence was found regarding treatment of preterm babies with GORD (<a href="./references#CD011785-bbs2-0103" title="TigheM , AfzalNA , BevanA , HayenA , MunroA , BeattieRM . Pharmacological treatment of children with gastro‐oesophageal reflux. Cochrane Database of Systematic Reviews2014, Issue 11. [DOI: 10.1002/14651858.CD008550.pub2] ">Tighe 2014</a>). Current guidelines of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) do not make specific recommendations for treatment of newborn or preterm infants with GORD (<a href="./references#CD011785-bbs2-0104" title="VandenplasY , RudolphCD , DiLorenzoC , HassallE , LiptakG , MazurL , et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). Journal of Pediatric Gastroenterology and Nutrition2009;49(4):498‐547. ">Vandenplas 2009</a>). The Italian Society of Pediatric Gastroenterology identified three classes of drugs for use in paediatric gastrointestinal bleeding (acid suppression drugs, vasoactive drugs and non‐selective β‐blockers) but notes the literature supporting use of these agents is limited to RCTs in adults (<a href="./references#CD011785-bbs2-0096" title="RomanoC , OlivaS , MartellossiS , MieleE , ArrigoS , GrazianiMG , CardileS , GaianiF , de'AngelisGL , TorroniF . Pediatric gastrointestinal bleeding: Perspectives from the Italian Society of Pediatric Gastroenterology. World Journal of Gastroenterology2017;23:1328‐37. ">Romano 2017</a>). No guidelines were found that specifically address upper gastrointestinal bleeding in newborn infants. Given that sick newborn infants at risk of, and newborn infants with, upper gastrointestinal bleeding are frequently treated with inhibitors of gastric acid secretion, that bleeding can be severe, and that the safety of treatment has not been reviewed in newborn infants, a systematic review of prevention and treatment was needed. The lack of guidelines/consensus on pharmacological prophylaxis and treatment of upper gastrointestinal bleeding in neonates formed the basis for this Cochrane Review. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011785-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011785-sec-0035"></div> <p>To assess how different pharmacological interventions (PPIs, H2RAs, antacids, sucralfate or bismuth salts) administered to preterm and term neonates for the prevention or treatment of upper gastrointestinal bleeding to reduce morbidity and mortality compare with placebo or no treatment, supportive care, or each other. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011785-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011785-sec-0036"></div> <section id="CD011785-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011785-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs), quasi‐RCTs and cluster‐RCTs.</p> </section> <section id="CD011785-sec-0039"> <h4 class="title">Types of participants</h4> <p>We considered all preterm and term infants with, or at risk of, upper gastrointestinal bleeding as eligible for inclusion. </p> <p>We defined infants at risk of upper gastrointestinal bleeding as those with known upper gastrointestinal bleeding risk factors including born at preterm gestation, birth asphyxia, mechanical ventilation, hypotension, neonatal cyanosis and neonatal seizures (<a href="./references#CD011785-bbs2-0080" title="KuuselaAL , MäkiM , RuuskaT , LaippalaP . Stress‐induced gastric findings in critically ill newborn infants: frequency and risk factors. Intensive Care Medicine2000;26(10):1501‐6. [PUBMED: 11126263] ">Kuusela 2000</a>; <a href="./references#CD011785-bbs2-0093" title="OmbevaOM , NdeeziG , MugaluJ . Upper GI bleeding among neonates admitted to Mulago Hospital, Kampala, Uganda: a prospective cohort study. African Health Sciences2013;13(3):741‐7. [DOI: 10.4314/ahs.v13i3.32; PUBMED: 24250316] ">Ombeva 2013</a>). </p> <p>We defined upper gastrointestinal bleeding as: the macroscopic presence of bloodstained material or material like coffee grounds in gastric aspirates or haematemesis; the microscopic presence of blood in gastric aspirates or haematemesis; or endoscopic examination of the gastric mucosa for bleeding lesions (<a href="./references#CD011785-bbs2-0074" title="GreenBT , RockeyDC . Acute gastrointestinal bleeding. Seminars in Gastrointestinal Disease2003;14(2):44‐65. [PUBMED: 12889580] ">Green 2003</a>). We excluded infants who had swallowed maternal blood. </p> </section> <section id="CD011785-sec-0040"> <h4 class="title">Types of interventions</h4> <p>Pharmacological intervention (H2RAs, PPIs, antacids, sucralfate, bismuth salts, or any combination) administered enterally or parenterally at any dose or frequency with or without co‐administration with other modalities (e.g. ceasing oral feeds; ceasing NSAIDs) with the intention of preventing or treating upper gastrointestinal bleeding, compared with each other, placebo, no intervention or supportive therapy. </p> <p>We excluded treatment trials for upper gastrointestinal bleeding aimed at correcting underlying bleeding disorders, such as vitamin K administration for vitamin K deficiency or fresh frozen plasma transfusion, as these have already been described in previous Cochrane Reviews (<a href="./references#CD011785-bbs2-0061" title="ArdellS , OffringaM , SollR . Prophylactic vitamin K for the prevention of vitamin K deficiency bleeding in preterm neonates. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD008342; PUBMED: 29401369] ">Ardell 2010</a>; <a href="./references#CD011785-bbs2-0094" title="PuckettRM , OffringaM . Prophylactic vitamin K for vitamin K deficiency bleeding in neonates. Cochrane Database of Systematic Reviews2000, Issue 4. [DOI: 10.1002/14651858.CD002776; PUBMED: 11034761] ">Puckett 2000</a>). </p> <p>We planned to analyse the following comparisons.</p> <section id="CD011785-sec-0041"> <h5 class="title">a) Comparisons between drug classes</h5> <p> <ol id="CD011785-list-0002"> <li> <p>PPIs vs. H2RAs;</p> </li> <li> <p>PPIs vs. antacids;</p> </li> <li> <p>PPIs vs. bismuth;</p> </li> <li> <p>PPIs vs. sucralfate;</p> </li> <li> <p>PPIs vs. placebo, no treatment or supportive care;</p> </li> <li> <p>H2RAs vs. antacids;</p> </li> <li> <p>H2RAs vs. bismuth;</p> </li> <li> <p>H2RAs vs. sucralfate;</p> </li> <li> <p>H2RAs vs. placebo, no treatment or supportive care;</p> </li> <li> <p>Antacids vs. bismuth;</p> </li> <li> <p>Antacids vs. sucralfate;</p> </li> <li> <p>Antacids vs. placebo, no treatment or supportive care;</p> </li> <li> <p>Bismuth vs. sucralfate;</p> </li> <li> <p>Bismuth vs. placebo, no treatment or supportive care;</p> </li> <li> <p>Sucralfate vs. placebo, no treatment or supportive care.</p> </li> </ol> </p> </section> <section id="CD011785-sec-0042"> <h5 class="title">b) Comparisons between specific drugs of different classes</h5> <p> <ol id="CD011785-list-0003"> <li> <p>Specific H2RAs vs. specific PPIs;</p> </li> <li> <p>Specific antacids vs. specific PPIs;</p> </li> <li> <p>Bismuth vs. specific PPIs;</p> </li> <li> <p>Sucralfate vs. specific PPIs;</p> </li> <li> <p>Specific antacid vs. specific H2RAs;</p> </li> <li> <p>Bismuth vs. specific H2RAs;</p> </li> <li> <p>Sucralfate vs. specific H2RAs;</p> </li> <li> <p>Specific antacids vs. bismuth;</p> </li> <li> <p>Specific antacids vs. sucralfate;</p> </li> <li> <p>Bismuth vs. sucralfate.</p> </li> </ol> </p> </section> <section id="CD011785-sec-0043"> <h5 class="title">c) Comparison between specific drugs within a drug class</h5> <p> <ol id="CD011785-list-0004"> <li> <p>Specific H2RAs vs. specific H2RAs;</p> </li> <li> <p>Specific PPIs vs. specific PPIs;</p> </li> <li> <p>Specific antacids vs. specific antacids.</p> </li> </ol> </p> </section> <section id="CD011785-sec-0044"> <h5 class="title">d) Comparisons of combinations of specific drugs</h5> <p> <ol id="CD011785-list-0005"> <li> <p>H2RAs plus one or more of the following: antacids, sucralfate or bismuth salts vs. PPIs; </p> </li> <li> <p>H2RAs plus one or more of the following: antacids, sucralfate or bismuth salts vs. placebo, no treatment or supportive care; </p> </li> <li> <p>PPIs plus one or more of the following; antacids, sucralfate or bismuth salts. vs. H2RAs; </p> </li> <li> <p>PPIs plus one or more of the following; antacids, sucralfate or bismuth salts. vs. placebo, no treatment or supportive care. </p> </li> </ol> </p> </section> </section> <section id="CD011785-sec-0045"> <h4 class="title">Types of outcome measures</h4> <section id="CD011785-sec-0046"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD011785-list-0006"> <li> <p>All‐cause mortality to near‐term age or discharge.</p> </li> <li> <p>Any upper gastrointestinal bleeding in infants at risk of upper gastrointestinal bleeding.</p> </li> <li> <p>Duration of upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding (days). </p> </li> </ol> </p> </section> <section id="CD011785-sec-0047"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD011785-list-0007"> <li> <p>Gastric lesions detected by endoscopy and macroscopically.</p> </li> <li> <p>All‐cause infant mortality (i.e. &lt; 1 year of age).</p> </li> <li> <p>Anaemia requiring blood transfusion.</p> </li> <li> <p>Volume of blood transfused for treatment of upper gastrointestinal bleeding (mL/kg).</p> </li> <li> <p>Number of blood transfusions for treatment of upper gastrointestinal bleeding.</p> </li> <li> <p>Necrotising enterocolitis (NEC) as defined by Bell stages 1 to 4 (confirmed = Bell stage 2 or greater) (<a href="./references#CD011785-bbs2-0065" title="BellMJ , TernbergJL , FeiginRD , KeatingJP , MarshallR , BartonL , et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Annals of Surgery1978;187(1):1‐7. [PUBMED: PMC1396409] ">Bell 1978</a>). </p> </li> <li> <p>Time to full feeds (days).</p> </li> <li> <p>Duration of total parenteral nutrition (days).</p> </li> <li> <p>Proven infection (culture positive from a normally sterile site).</p> </li> <li> <p>Neonatal cholestasis ('serum conjugated bilirubin concentration &gt; 17.1 µM and total serum bilirubin &lt; 85.5 µM' or 'serum conjugated bilirubin concentration &gt; 20% of total serum bilirubin if total serum bilirubin is &gt; 85.5 µM'). </p> </li> <li> <p>Ventilator‐associated pneumonia (new or progressive infiltrate with positive respiratory specimens after 48 hours of mechanical ventilation). </p> </li> <li> <p>Neonatal chronic lung disease (also known as bronchopulmonary dysplasia) (defined according to the 2001 National Institute of Child Health and Development criteria (<a href="./references#CD011785-bbs2-0077" title="JobeAH , BancalariE . Bronchopulmonary dysplasia. American Journal of Respiratory and Critical Care Medicine2001;163:1723‐9. [DOI: doi.org/10.1164/ajrccm.163.7.2011060; PUBMED: 11401896] ">Jobe 2001</a>): treatment with oxygen &gt; 21% for at least 28 days). </p> </li> <li> <p>Duration of ventilation (days).</p> </li> <li> <p>Duration of respiratory support (days).</p> </li> <li> <p>Duration of hospital stay (days).</p> </li> <li> <p>Neurodevelopmental disability (defined as neurological abnormality including cerebral palsy on clinical examination or global developmental delay (two or more standard deviations (SDs) below population mean on Bayley Scales of Infant Development or Griffiths Mental Development Scales at any time after term corrected at 1 year, 18 months, 2 years and 5 years postnatal age). </p> </li> <li> <p>Haemorrhagic shock (at least 15% blood loss).</p> </li> <li> <p>Thrombocytopenia (platelet count &lt; 150,000/µL).</p> </li> <li> <p>Retinopathy of prematurity or other severe adverse events.</p> </li> <li> <p>Serious adverse reactions (potentially related to pharmacological intervention) (post hoc addition to protocol). </p> </li> </ol> </p> </section> </section> </section> <section id="CD011785-sec-0048"> <h3 class="title">Search methods for identification of studies</h3> <p>We used the criteria and standard methods of Cochrane and Cochrane Neonatal (see the Cochrane Neonatal <a href="http://neonatal.cochrane.org/resources-review-authors" target="_blank">search strategy</a> for specialized register). We searched for errata or retractions from included studies published in full text on PubMed (<a href="http://www.ncbi.nlm.nih.gov/pubmed" target="_blank">www.ncbi.nlm.nih.gov/pubmed</a>) on 12 July 2018. We did not limit the search to any particular geographical region, language or timing of publication. Unpublished studies were eligible for review. </p> <section id="CD011785-sec-0049"> <h4 class="title">Electronic searches</h4> <p>We conducted a comprehensive search — including Cochrane Central Register of Controlled Trials (CENTRAL 2018, Issue 6) in the Cochrane Library, MEDLINE via PubMed (1966 to 12 July 2018), Embase (1980 to 12 July 2018), and CINAHL (1982 to 12 July 2018) — using topic‐specific search terms, plus database‐specific limiters for RCTs and neonates (see <a href="./appendices#CD011785-sec-0111">Appendix 1</a> for the full search strategies for each database). We did not apply language restrictions. </p> </section> <section id="CD011785-sec-0050"> <h4 class="title">Searching other resources</h4> <p>We conducted additional searches of the following resources.</p> <p>1. Ongoing trials in the following trial registries.</p> <p> <ul id="CD011785-list-0008"> <li> <p><a href="http://www.clinicaltrials.gov/" target="_blank">ClinicalTrials.gov (U.S. National Institutes of Health)</a>; </p> </li> <li> <p><a href="http://www.who.int/ictrp/en/" target="_blank">World Health Organization International Clinical Trials Registry Platform (ICTRP)</a>; </p> </li> <li> <p><a href="http://www.isrctn.com/" target="_blank">ISRCTN registry</a>; </p> </li> <li> <p><a href="http://www.anzctr.org.au/" target="_blank">Australian New Zealand Clinical Trials Registry</a>. </p> </li> </ul> </p> <p>2. Conference abstracts from the following.</p> <p> <ul id="CD011785-list-0009"> <li> <p>Proceedings of the Pediatric Academic Societies (American Pediatric Society, Society for Pediatric Research and European Society for Pediatric Research) from 1990 to current from the journal <i>Pediatric Research and Abstracts Online.</i> </p> </li> <li> <p>Proceedings of the European Academy of Paediatric Societies (EAPS) (The European Society for Paediatric Research (ESPR), the European Academy of Paediatrics (EAP) and the European Society of Paediatric and Neonatal Intensive Care (ESPNIC) from 2003 to current from Abstracts Online). </p> </li> <li> <p>Proceedings of the Perinatal Society of Australia and New Zealand (PSANZ) from 1996 to current (handsearch). </p> </li> </ul> </p> <p>3. Reference lists: after reading the identified individual studies, we screened the reference lists of these papers to identify further relevant studies about upper gastrointestinal bleeding. </p> <p>4. Personal communications.</p> <p> <ul id="CD011785-list-0010"> <li> <p>Where unpublished trials were identified, we contacted the corresponding investigator for information on any unpublished trials potentially eligible for inclusion. Unpublished studies will be eligible for review. </p> </li> <li> <p>We contacted the corresponding authors of identified RCTs for additional information where necessary. </p> </li> </ul> </p> <p>5. Pharmaceutical companies: we contacted the respective pharmaceutical companies responsible for developments of H2RA, PPI, antacid, sucralfate or bismuth salts products used in the prevention or treatment of upper gastrointestinal bleeding for unpublished studies. </p> <p>4. Chinese language articles from <a href="http://caod.oriprobe.com" target="_blank">China/Asia On Demand (CAOD)</a>. </p> </section> </section> <section id="CD011785-sec-0051"> <h3 class="title" id="CD011785-sec-0051">Data collection and analysis</h3> <p>We used the standard methods of the Cochrane Neonatal Review Group and Cochrane, as documented in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011785-bbs2-0075" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> <section id="CD011785-sec-0052"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed studies identified for inclusion. We resolved any differences through discussion and consensus. </p> </section> <section id="CD011785-sec-0053"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (DG, MA) independently extracted data using specifically designed data extraction forms. We resolved disagreements through discussion and consensus with a third author (DO). We used the retrieved information to determine trial eligibility, to extract methods and data from eligible trials and for requesting additional unpublished information from authors of original reports. We used <a href="./references#CD011785-bbs2-0095" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a> to enter and cross‐check data. </p> </section> <section id="CD011785-sec-0054"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (DG and MA) independently assessed the risk of bias (low, high, or unclear) of all included trials in the following domains, using the Cochrane ‘Risk of bias’ tool (<a href="./references#CD011785-bbs2-0076" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017. Available from training.cochrane.org/handbook. ">Higgins 2017</a>). </p> <p> <ul id="CD011785-list-0011"> <li> <p>Sequence generation (selection bias).</p> </li> <li> <p>Allocation concealment (selection bias).</p> </li> <li> <p>Blinding of participants and personnel (performance bias).</p> </li> <li> <p>Blinding of outcome assessment (detection bias).</p> </li> <li> <p>Incomplete outcome data (attrition bias).</p> </li> <li> <p>Selective reporting (reporting bias).</p> </li> <li> <p>Any other bias.</p> </li> </ul> </p> <p>When necessary, we requested additional information and clarification of published data from trial authors. We resolved any disagreements by discussion or by inviting a third assessor to arbitrate. See <a href="https://archie.cochrane.org/sections/documents/view?version=z1602121707269037293463533411836%26format=REVMAN#APP-02" target="_blank">Appendix 2</a> for a more detailed description of risk of bias for each domain. </p> </section> <section id="CD011785-sec-0055"> <h4 class="title">Measures of treatment effect</h4> <p>We carried out statistical analyses using <a href="./references#CD011785-bbs2-0095" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>. </p> <section id="CD011785-sec-0056"> <h5 class="title">Dichotomous Data</h5> <p>We reported dichotomous data using risk ratios (RRs) with 95% confidence intervals (CIs). We calculated risk difference (RD) and number needed to treat for an additional beneficial outcome (NNTB) or for an additional harmful outcome (NNTH) with 95% CIs where there was a statistically significant difference in RR. </p> </section> <section id="CD011785-sec-0057"> <h5 class="title">Continuous Data</h5> <p>We reported continuous data using mean difference (MD) with 95% CI.</p> </section> </section> <section id="CD011785-sec-0058"> <h4 class="title">Unit of analysis issues</h4> <p>When assessing individually randomised controlled trials, the unit of analysis was the participating infant. However, in cluster‐RCTs we planned to use the neonatal unit or the cluster that is randomised as the unit of analysis. We planned to include cluster‐RCTs in the analyses using an estimate of the intra‐cluster correlation co‐efficient (ICC) derived from the trial (if possible), or from another source, as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011785-bbs2-0075" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). If ICCs from other sources were used, we planned to report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identified both cluster‐RCTs and individual RCTs, we planned to synthesise the relevant information. We considered it reasonable to combine the results from both if there was little heterogeneity between study designs, and the interaction between the effect of intervention and the choice of randomisation unit was considered to be unlikely. As it turned out, we included no cluster‐RCTs in this Cochrane Review. </p> </section> <section id="CD011785-sec-0059"> <h4 class="title">Dealing with missing data</h4> <p>We obtained missing data from the trial authors when possible. If this was not possible, we conducted analyses on available data (i.e. ignoring the missing data). In addition, we conducted another analysis by using the imputation method (both best‐ and worst‐case scenarios) and the last observation carried forward to the final assessment (LOCF) method for dichotomous and continuous outcome data respectively. For dichotomous outcomes, we conducted both best‐ and worst‐case scenarios and intention‐to‐treat (ITT) analyses with imputation. We planned to compare results obtained from two analysis options to have a better understanding of the robustness of results relative to the different analytic approaches. We considered an imputation approach of best‐case scenarios (i.e. all missing participants in the intervention group did not experience poor outcomes (e.g. death) and all missing participants in the control group experienced poor outcomes); and worst‐case scenarios (i.e. all missing participants in the intervention group experienced the event and all missing participants in the control condition did not). We planned to conduct sensitivity analysis to compare results based on different imputation assumptions (i.e. best‐case vs. worst‐case scenarios). We analysed missing continuous data on an endpoint basis, including only participants with a final assessment, or using LOCF if trial authors reported these data. </p> </section> <section id="CD011785-sec-0060"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used <a href="./references#CD011785-bbs2-0095" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a> to assess the heterogeneity of treatment effects between trials. We undertook this assessment using the following two formal statistical models. </p> <p> <ol id="CD011785-list-0012"> <li> <p>The Chi² test, to assess whether observed variability in effect sizes between studies is greater than would be expected by chance. Since this test has low power when the number of studies included in the meta‐analysis is small, we set the probability at the 10% level of significance. </p> </li> <li> <p>The I² statistic, to ensure that pooling of data is valid. We graded the degree of heterogeneity as either none (&lt; 25%), low (25% to 49%), moderate (50% to 74%) or high (75% to 100%). Where there was evidence of apparent or statistical heterogeneity, we assessed the source of the heterogeneity using sensitivity and subgroup analyses, looking for evidence of bias or methodological differences between trials. </p> </li> </ol> </p> </section> <section id="CD011785-sec-0061"> <h4 class="title">Assessment of reporting biases</h4> <p>We were unable to assess reporting and publication bias by examining degree of asymmetry of funnel plots in Review Manager 5, as all analyses reported on fewer than 10 studies (<a href="./references#CD011785-bbs2-0095" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). </p> </section> <section id="CD011785-sec-0062"> <h4 class="title">Data synthesis</h4> <p>We performed statistical analyses according to the recommendations of the Cochrane Neonatal Review Group (<a href="http://neonatal.cochrane.org" target="_blank">neonatal.cochrane.org</a>). We analysed all infants randomised on an ITT basis and treatment effects in the individual trials. We used a fixed‐effect model to combine the data. For any meta‐analyses analysing categorical outcomes, we calculated typical estimates of RR and RD, each with 95% CIs. For any meta‐analyses analysing continuous outcomes, we calculated the weighted mean difference (WMD) with 95% CIs if outcomes were measured in the same way between trials, and standardized mean difference (SMD) with 95% CIs to combine trials that measure the same outcome using different scales. If high heterogeneity had been apparent, we planned not to report a typical effect. When meta‐analysis was judged to be inappropriate, we analysed and interpreted individual trials separately. </p> <section id="CD011785-sec-0063"> <h5 class="title">Quality of evidence</h5> <p>We used the GRADE approach, as outlined in the GRADE Handbook (<a href="./references#CD011785-bbs2-0098" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s) . Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html. ">Schünemann 2013</a>), to assess the quality of evidence for the following (clinically relevant) outcomes. </p> <p> <ol id="CD011785-list-0013"> <li> <p>All‐cause mortality to near‐term age or discharge.</p> </li> <li> <p>Any upper gastrointestinal bleeding in infants at risk of upper gastrointestinal bleeding.</p> </li> <li> <p>Duration of any upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding (days). </p> </li> <li> <p>Anaemia requiring blood transfusion.</p> </li> <li> <p>NEC as defined by Bell stages 1 to 4.</p> </li> <li> <p>Ventilator‐associated pneumonia (new or progressive infiltrate with positive respiratory specimens after 48 hours of mechanical ventilation). </p> </li> <li> <p>Duration of hospital stay (days).</p> </li> </ol> </p> <p>Two authors (DG, MA) independently assessed the quality of the evidence for each of the outcomes above. We considered evidence from randomised controlled trials as high quality but downgraded the evidence one level for serious (or two levels for very serious) limitations based upon the following: design (risk of bias), consistency across studies, directness of the evidence, precision of estimates and presence of publication bias. We used the <a href="./references#CD011785-bbs2-0072" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 12 July 2018. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT</a> Guideline Development Tool to create a ‘Summary of findings’ table to report the quality of the evidence. </p> <p>The GRADE approach results in an assessment of the quality of a body of evidence in one of four grades. </p> <p> <ol id="CD011785-list-0014"> <li> <p>High: we are very confident that the true effect lies close to that of the estimate of the effect. </p> </li> <li> <p>Moderate: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> </li> <li> <p>Low: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. </p> </li> <li> <p>Very low: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </li> </ol> </p> </section> </section> <section id="CD011785-sec-0064"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Where sufficient data were available, we explored potential sources of clinical heterogeneity through the following a priori subgroup analyses. </p> <p> <ol id="CD011785-list-0015"> <li> <p>Gestational age (&lt; 32' weeks, 32' to 36' weeks, or &gt; 36 weeks' gestation).</p> </li> <li> <p>Weight for age z‐score.</p> </li> <li> <p>Risk factor present for the development of upper gastrointestinal bleeding (e.g. stress‐induced gastritis or ulcers; trauma or mechanical ventilation; NSAID use; preterm birth; birth‐asphyxiation; neonatal cyanosis; neonatal seizures). </p> </li> <li> <p>Higher vs. lower dose of pharmacological intervention (median dosing recommendation as the threshold). </p> </li> </ol> </p> </section> <section id="CD011785-sec-0065"> <h4 class="title">Sensitivity analysis</h4> <p>Where sufficient data were available, we explored methodological heterogeneity through sensitivity analyses. We performed these by including only those trials with adequate allocation concealment, randomisation or blinding of treatment and less than 10% loss to follow‐up. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011785-sec-0066" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011785-sec-0066"></div> <section id="CD011785-sec-0067"> <h3 class="title">Description of studies</h3> <section id="CD011785-sec-0068"> <h4 class="title">Results of the search</h4> <p>We screened a total of 388 records (see <a href="#CD011785-fig-0001">Figure 1</a>). We identified 296 records through database searching of PubMed, Embase, CINAHL, and the Cochrane Central Register of Controlled Trials, as detailed in <a href="#CD011785-sec-0048">Search methods for identification of studies</a> above. Two hundred and fifty records remained after de‐duplication. We identified an additional 53 records through searches of the Chinese literature via China National Knowledge Infrastructure (CNKI) and CAOD (China/Asia on Demand) services; and 85 records were found through searches of <a href="http://clinicaltrials.gov" target="_blank">ClinicalTrials.gov</a>, <a href="http://www.isrctn.com/" target="_blank">ISRCTN registry</a>, <a href="http://www.who.int/ictrp/en/" target="_blank">World Health Organization International Clinical Trials Registry Platform (ICTRP)</a>, <a href="http://www.anzctr.org.au/" target="_blank">Australian New Zealand Clinical Trials Registry</a> and conference abstracts/proceedings. </p> <div class="figure" id="CD011785-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD011785-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD011785-sec-0069"> <h4 class="title">Included studies</h4> <p>We assessed 11 trials as eligible for inclusion (see <a href="./references#CD011785-sec-0120" title="">Characteristics of included studies</a>): seven were trials of treatment in infants with active gastrointestinal bleeding and four were trials of prevention of gastrointestinal bleeding in high‐risk infants. </p> <section id="CD011785-sec-0070"> <h5 class="title">Participants</h5> <section id="CD011785-sec-0071"> <h6 class="title">Prevention of upper gastrointestinal bleeding</h6> <p>Four trials enrolled infants at high risk of gastrointestinal bleeding with the goal of preventing gastrointestinal haemorrhage (<a href="./references#CD011785-bbs2-0002" title="HanM , YeXQ , YuanJQ . Cimetidine in prevention of acute gastric mucosal lesion of newborns. Journal of Bengbu Medical College2001;26(4):315‐6. ">Han 2001</a>; <a href="./references#CD011785-bbs2-0004" title="KuuselaAL , RuuskaT , KarikoskiR , LaippalaP , IkonenRS , JanasM , et al. A randomized, controlled study of prophylactic ranitidine in preventing stress‐induced gastric mucosal lesions in neonatal intensive care unit patients. Critical Care Medicine1997;25(2):346‐51. [PUBMED: 9034275] ">Kuusela 1997</a>; <a href="./references#CD011785-bbs2-0007" title="LuWQ . The effect of cimetidine in preventing from acute gastric mucosal lesion of neonates. Journal of Neonatology1995;10(1):23‐4. ">Lu 1995</a>; <a href="./references#CD011785-bbs2-0008" title="PourarianS , ImaniB , ImaniehMH . Prophylactic ranitidine in prevention of GI bleeding in neonatal intensive care units. Iranian Journal of Medical Sciences2005;30(4):178‐81. ">Pourarian 2005</a>). The criteria for enrolment included term and preterm newborns with severe illness (<a href="./references#CD011785-bbs2-0002" title="HanM , YeXQ , YuanJQ . Cimetidine in prevention of acute gastric mucosal lesion of newborns. Journal of Bengbu Medical College2001;26(4):315‐6. ">Han 2001</a>; <a href="./references#CD011785-bbs2-0007" title="LuWQ . The effect of cimetidine in preventing from acute gastric mucosal lesion of neonates. Journal of Neonatology1995;10(1):23‐4. ">Lu 1995</a>); newborns commencing mechanical ventilation in the first two days (<a href="./references#CD011785-bbs2-0004" title="KuuselaAL , RuuskaT , KarikoskiR , LaippalaP , IkonenRS , JanasM , et al. A randomized, controlled study of prophylactic ranitidine in preventing stress‐induced gastric mucosal lesions in neonatal intensive care unit patients. Critical Care Medicine1997;25(2):346‐51. [PUBMED: 9034275] ">Kuusela 1997</a>); and term and preterm newborns admitted to a neonatal intensive care unit (NICU) (<a href="./references#CD011785-bbs2-0008" title="PourarianS , ImaniB , ImaniehMH . Prophylactic ranitidine in prevention of GI bleeding in neonatal intensive care units. Iranian Journal of Medical Sciences2005;30(4):178‐81. ">Pourarian 2005</a>). </p> </section> <section id="CD011785-sec-0072"> <h6 class="title">Treatment of upper gastrointestinal bleeding</h6> <p>Seven trials enrolled infants with active gastrointestinal bleeding (<a href="./references#CD011785-bbs2-0001" title="DengHL , LongJH , MoK . Investigation of the effects of Omeprazole therapy on neonates with upper gastrointestinal hemorrhage. Hebei Medicine2005;11(8):723‐5. ">Deng 2005</a>; <a href="./references#CD011785-bbs2-0003" title="HuoK . Cimetidine in treating upper alimentary canal hemorrhage after critical neonates in 42 cases. Journal of Pediatric Pharmacy2001;7(3):25‐6. ">Huo 2001</a>; <a href="./references#CD011785-bbs2-0005" title="LinXY . The efficacy of stomach injection method applied stress ulcer omeprazole treatment of neonatal. China Practical Medicine2011;6(32):14‐5. ">Lin 2011</a>; <a href="./references#CD011785-bbs2-0006" title="LiuH . Observations of effect of Famotidine on hemorrhage of digestive tract in newborn. China Journal of Modern Medicine2005;15(12):1870‐1, 4. ">Liu 2005</a>; <a href="./references#CD011785-bbs2-0009" title="SarnaMS , SailiA , DuttaAK , SharmaD . Stress associated gastric bleeding in newborn‐‐role of ranitidine. Indian Pediatrics1991;28(11):1305‐8. [PUBMED: 1808052] ">Sarna 1991</a>; <a href="./references#CD011785-bbs2-0010" title="YangJ , ZhaoQM , ZhangY . Ranitidine and smecta in treatment of neonates with upper gastrointestinal hemorrhage. Journal of Pediatric Pharmacy2004;10(2):38‐9. ">Yang 2004</a>; <a href="./references#CD011785-bbs2-0011" title="YangD . The efficacy observation of Omeprazole in treatment of neonatal stress ulcer. China Health Standard Management2015;6(7):221‐2. ">Yang 2015</a>). Five studies reported enrolling term and preterm newborns with severe illness (<a href="./references#CD011785-bbs2-0003" title="HuoK . Cimetidine in treating upper alimentary canal hemorrhage after critical neonates in 42 cases. Journal of Pediatric Pharmacy2001;7(3):25‐6. ">Huo 2001</a>; <a href="./references#CD011785-bbs2-0005" title="LinXY . The efficacy of stomach injection method applied stress ulcer omeprazole treatment of neonatal. China Practical Medicine2011;6(32):14‐5. ">Lin 2011</a>; <a href="./references#CD011785-bbs2-0006" title="LiuH . Observations of effect of Famotidine on hemorrhage of digestive tract in newborn. China Journal of Modern Medicine2005;15(12):1870‐1, 4. ">Liu 2005</a>; <a href="./references#CD011785-bbs2-0010" title="YangJ , ZhaoQM , ZhangY . Ranitidine and smecta in treatment of neonates with upper gastrointestinal hemorrhage. Journal of Pediatric Pharmacy2004;10(2):38‐9. ">Yang 2004</a>; <a href="./references#CD011785-bbs2-0011" title="YangD . The efficacy observation of Omeprazole in treatment of neonatal stress ulcer. China Health Standard Management2015;6(7):221‐2. ">Yang 2015</a>); and two studies did not report illness severity (<a href="./references#CD011785-bbs2-0001" title="DengHL , LongJH , MoK . Investigation of the effects of Omeprazole therapy on neonates with upper gastrointestinal hemorrhage. Hebei Medicine2005;11(8):723‐5. ">Deng 2005</a>; <a href="./references#CD011785-bbs2-0009" title="SarnaMS , SailiA , DuttaAK , SharmaD . Stress associated gastric bleeding in newborn‐‐role of ranitidine. Indian Pediatrics1991;28(11):1305‐8. [PUBMED: 1808052] ">Sarna 1991</a>). </p> </section> </section> <section id="CD011785-sec-0073"> <h5 class="title">Interventions</h5> <section id="CD011785-sec-0074"> <h6 class="title">Prevention of upper gastrointestinal bleeding</h6> <p>All four studies compared an H2RA versus no treatment. <a href="./references#CD011785-bbs2-0002" title="HanM , YeXQ , YuanJQ . Cimetidine in prevention of acute gastric mucosal lesion of newborns. Journal of Bengbu Medical College2001;26(4):315‐6. ">Han 2001</a> compared cimetidine 5 mg/kg/day for five days versus no treatment; <a href="./references#CD011785-bbs2-0004" title="KuuselaAL , RuuskaT , KarikoskiR , LaippalaP , IkonenRS , JanasM , et al. A randomized, controlled study of prophylactic ranitidine in preventing stress‐induced gastric mucosal lesions in neonatal intensive care unit patients. Critical Care Medicine1997;25(2):346‐51. [PUBMED: 9034275] ">Kuusela 1997</a> compared ranitidine 5 mg/kg/day intravenously divided into three doses for four days versus no treatment; <a href="./references#CD011785-bbs2-0007" title="LuWQ . The effect of cimetidine in preventing from acute gastric mucosal lesion of neonates. Journal of Neonatology1995;10(1):23‐4. ">Lu 1995</a> compared cimetidine 5 mg/kg/dose intravenously twice daily for three to five days versus no treatment; and <a href="./references#CD011785-bbs2-0008" title="PourarianS , ImaniB , ImaniehMH . Prophylactic ranitidine in prevention of GI bleeding in neonatal intensive care units. Iranian Journal of Medical Sciences2005;30(4):178‐81. ">Pourarian 2005</a> compared ranitidine 5 mg/kg/day intravenously, three divided doses for four days irrespective of gastric pH, versus no treatment. </p> </section> <section id="CD011785-sec-0075"> <h6 class="title">Treatment of upper gastrointestinal bleeding</h6> <p>Four studies compared an H2RA versus no treatment. <a href="./references#CD011785-bbs2-0003" title="HuoK . Cimetidine in treating upper alimentary canal hemorrhage after critical neonates in 42 cases. Journal of Pediatric Pharmacy2001;7(3):25‐6. ">Huo 2001</a> compared cimetidine 3 mg/kg to 5 mg/kg intravenous six to eight hourly until bleeding stopped and then continued three to five days more versus no treatment; <a href="./references#CD011785-bbs2-0006" title="LiuH . Observations of effect of Famotidine on hemorrhage of digestive tract in newborn. China Journal of Modern Medicine2005;15(12):1870‐1, 4. ">Liu 2005</a> compared famotidine 0.3 mg/kg 12 hourly for 48 to 72 hours until bleeding ceased for 24 hours versus usual therapy (not reported); <a href="./references#CD011785-bbs2-0009" title="SarnaMS , SailiA , DuttaAK , SharmaD . Stress associated gastric bleeding in newborn‐‐role of ranitidine. Indian Pediatrics1991;28(11):1305‐8. [PUBMED: 1808052] ">Sarna 1991</a> compared ranitidine 0.6 mg/kg loading dose followed by 0.15 mg/kg/hour intravenous infusion until bleeding had ceased for 24 hours versus no treatment; and <a href="./references#CD011785-bbs2-0010" title="YangJ , ZhaoQM , ZhangY . Ranitidine and smecta in treatment of neonates with upper gastrointestinal hemorrhage. Journal of Pediatric Pharmacy2004;10(2):38‐9. ">Yang 2004</a> compared ranitidine 3 mg/kg/day to 5 mg/kg/day intravenously for three to five days, and Smecta 1/3 packet then 1/4 packet three times a day versus usual therapy (not reported). Three studies compared a proton pump inhibitor versus no treatment. <a href="./references#CD011785-bbs2-0001" title="DengHL , LongJH , MoK . Investigation of the effects of Omeprazole therapy on neonates with upper gastrointestinal hemorrhage. Hebei Medicine2005;11(8):723‐5. ">Deng 2005</a> compared omeprazole 1 mg/kg twice daily for five days plus usual therapy versus usual therapy (not reported); <a href="./references#CD011785-bbs2-0005" title="LinXY . The efficacy of stomach injection method applied stress ulcer omeprazole treatment of neonatal. China Practical Medicine2011;6(32):14‐5. ">Lin 2011</a> compared omeprazole 0.6 mg/kg intragastric once daily for five days plus usual therapy versus usual therapy (nil by mouth, stomach washed with bicarbonate); and <a href="./references#CD011785-bbs2-0011" title="YangD . The efficacy observation of Omeprazole in treatment of neonatal stress ulcer. China Health Standard Management2015;6(7):221‐2. ">Yang 2015</a> compared omeprazole 0.7 mg/kg intragastric daily for five days versus usual therapy (not reported). </p> </section> </section> <section id="CD011785-sec-0076"> <h5 class="title">Outcomes</h5> <section id="CD011785-sec-0077"> <h6 class="title">Primary outcomes</h6> <p>Mortality was only reported in three of the 11 trials, reporting outcomes of 184 infants (<a href="./references#CD011785-bbs2-0003" title="HuoK . Cimetidine in treating upper alimentary canal hemorrhage after critical neonates in 42 cases. Journal of Pediatric Pharmacy2001;7(3):25‐6. ">Huo 2001</a>; <a href="./references#CD011785-bbs2-0004" title="KuuselaAL , RuuskaT , KarikoskiR , LaippalaP , IkonenRS , JanasM , et al. A randomized, controlled study of prophylactic ranitidine in preventing stress‐induced gastric mucosal lesions in neonatal intensive care unit patients. Critical Care Medicine1997;25(2):346‐51. [PUBMED: 9034275] ">Kuusela 1997</a>; <a href="./references#CD011785-bbs2-0009" title="SarnaMS , SailiA , DuttaAK , SharmaD . Stress associated gastric bleeding in newborn‐‐role of ranitidine. Indian Pediatrics1991;28(11):1305‐8. [PUBMED: 1808052] ">Sarna 1991</a>). Any upper gastrointestinal bleeding in infants at risk of upper gastrointestinal bleeding was reported by all four studies of prevention of gastrointestinal bleeding (<a href="./references#CD011785-bbs2-0002" title="HanM , YeXQ , YuanJQ . Cimetidine in prevention of acute gastric mucosal lesion of newborns. Journal of Bengbu Medical College2001;26(4):315‐6. ">Han 2001</a>; <a href="./references#CD011785-bbs2-0004" title="KuuselaAL , RuuskaT , KarikoskiR , LaippalaP , IkonenRS , JanasM , et al. A randomized, controlled study of prophylactic ranitidine in preventing stress‐induced gastric mucosal lesions in neonatal intensive care unit patients. Critical Care Medicine1997;25(2):346‐51. [PUBMED: 9034275] ">Kuusela 1997</a>; <a href="./references#CD011785-bbs2-0007" title="LuWQ . The effect of cimetidine in preventing from acute gastric mucosal lesion of neonates. Journal of Neonatology1995;10(1):23‐4. ">Lu 1995</a>; <a href="./references#CD011785-bbs2-0008" title="PourarianS , ImaniB , ImaniehMH . Prophylactic ranitidine in prevention of GI bleeding in neonatal intensive care units. Iranian Journal of Medical Sciences2005;30(4):178‐81. ">Pourarian 2005</a>). Duration of upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding was reported by two of seven trials of treatment of gastrointestinal bleeding (<a href="./references#CD011785-bbs2-0001" title="DengHL , LongJH , MoK . Investigation of the effects of Omeprazole therapy on neonates with upper gastrointestinal hemorrhage. Hebei Medicine2005;11(8):723‐5. ">Deng 2005</a>; <a href="./references#CD011785-bbs2-0009" title="SarnaMS , SailiA , DuttaAK , SharmaD . Stress associated gastric bleeding in newborn‐‐role of ranitidine. Indian Pediatrics1991;28(11):1305‐8. [PUBMED: 1808052] ">Sarna 1991</a>). Continued upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding was also reported by six of seven trials of treatment of gastrointestinal bleeding (<a href="./references#CD011785-bbs2-0001" title="DengHL , LongJH , MoK . Investigation of the effects of Omeprazole therapy on neonates with upper gastrointestinal hemorrhage. Hebei Medicine2005;11(8):723‐5. ">Deng 2005</a>; <a href="./references#CD011785-bbs2-0003" title="HuoK . Cimetidine in treating upper alimentary canal hemorrhage after critical neonates in 42 cases. Journal of Pediatric Pharmacy2001;7(3):25‐6. ">Huo 2001</a>; <a href="./references#CD011785-bbs2-0005" title="LinXY . The efficacy of stomach injection method applied stress ulcer omeprazole treatment of neonatal. China Practical Medicine2011;6(32):14‐5. ">Lin 2011</a>; <a href="./references#CD011785-bbs2-0006" title="LiuH . Observations of effect of Famotidine on hemorrhage of digestive tract in newborn. China Journal of Modern Medicine2005;15(12):1870‐1, 4. ">Liu 2005</a>; <a href="./references#CD011785-bbs2-0010" title="YangJ , ZhaoQM , ZhangY . Ranitidine and smecta in treatment of neonates with upper gastrointestinal hemorrhage. Journal of Pediatric Pharmacy2004;10(2):38‐9. ">Yang 2004</a>; <a href="./references#CD011785-bbs2-0011" title="YangD . The efficacy observation of Omeprazole in treatment of neonatal stress ulcer. China Health Standard Management2015;6(7):221‐2. ">Yang 2015</a>). </p> </section> <section id="CD011785-sec-0078"> <h6 class="title">Secondary outcomes</h6> <p>Data were only reported or extractable for a minority of prespecified outcomes including gastric lesions detected by endoscopy and macroscopically (<a href="./references#CD011785-bbs2-0004" title="KuuselaAL , RuuskaT , KarikoskiR , LaippalaP , IkonenRS , JanasM , et al. A randomized, controlled study of prophylactic ranitidine in preventing stress‐induced gastric mucosal lesions in neonatal intensive care unit patients. Critical Care Medicine1997;25(2):346‐51. [PUBMED: 9034275] ">Kuusela 1997</a>); anaemia requiring blood transfusion, reported by one of 11 trials (<a href="./references#CD011785-bbs2-0009" title="SarnaMS , SailiA , DuttaAK , SharmaD . Stress associated gastric bleeding in newborn‐‐role of ranitidine. Indian Pediatrics1991;28(11):1305‐8. [PUBMED: 1808052] ">Sarna 1991</a>); and an absence of serious adverse reactions, reported by eight of the 11 trials (<a href="./references#CD011785-bbs2-0002" title="HanM , YeXQ , YuanJQ . Cimetidine in prevention of acute gastric mucosal lesion of newborns. Journal of Bengbu Medical College2001;26(4):315‐6. ">Han 2001</a>; <a href="./references#CD011785-bbs2-0003" title="HuoK . Cimetidine in treating upper alimentary canal hemorrhage after critical neonates in 42 cases. Journal of Pediatric Pharmacy2001;7(3):25‐6. ">Huo 2001</a>; <a href="./references#CD011785-bbs2-0004" title="KuuselaAL , RuuskaT , KarikoskiR , LaippalaP , IkonenRS , JanasM , et al. A randomized, controlled study of prophylactic ranitidine in preventing stress‐induced gastric mucosal lesions in neonatal intensive care unit patients. Critical Care Medicine1997;25(2):346‐51. [PUBMED: 9034275] ">Kuusela 1997</a>; <a href="./references#CD011785-bbs2-0006" title="LiuH . Observations of effect of Famotidine on hemorrhage of digestive tract in newborn. China Journal of Modern Medicine2005;15(12):1870‐1, 4. ">Liu 2005</a>; <a href="./references#CD011785-bbs2-0007" title="LuWQ . The effect of cimetidine in preventing from acute gastric mucosal lesion of neonates. Journal of Neonatology1995;10(1):23‐4. ">Lu 1995</a>; <a href="./references#CD011785-bbs2-0008" title="PourarianS , ImaniB , ImaniehMH . Prophylactic ranitidine in prevention of GI bleeding in neonatal intensive care units. Iranian Journal of Medical Sciences2005;30(4):178‐81. ">Pourarian 2005</a>; <a href="./references#CD011785-bbs2-0009" title="SarnaMS , SailiA , DuttaAK , SharmaD . Stress associated gastric bleeding in newborn‐‐role of ranitidine. Indian Pediatrics1991;28(11):1305‐8. [PUBMED: 1808052] ">Sarna 1991</a>; <a href="./references#CD011785-bbs2-0010" title="YangJ , ZhaoQM , ZhangY . Ranitidine and smecta in treatment of neonates with upper gastrointestinal hemorrhage. Journal of Pediatric Pharmacy2004;10(2):38‐9. ">Yang 2004</a>). <a href="./references#CD011785-bbs2-0010" title="YangJ , ZhaoQM , ZhangY . Ranitidine and smecta in treatment of neonates with upper gastrointestinal hemorrhage. Journal of Pediatric Pharmacy2004;10(2):38‐9. ">Yang 2004</a>, however, excluded infants with adverse reactions to medications after randomisation although numbers were unclear. No other neonatal morbidity or long‐term outcome was reported. </p> </section> </section> </section> <section id="CD011785-sec-0079"> <h4 class="title">Excluded studies</h4> <p>Forty‐six full‐text articles were excluded: 14 were not randomised controlled trials; 21 did not report eligible populations of infants; and 11 reported ineligible comparisons (see <a href="./references#CD011785-sec-0121" title="">Characteristics of excluded studies</a> and <a href="#CD011785-fig-0001">Figure 1</a>). </p> </section> </section> <section id="CD011785-sec-0080"> <h3 class="title">Risk of bias in included studies</h3> <p>See 'Risk of bias' graph and 'Risk of bias' summary (<a href="#CD011785-fig-0002">Figure 2</a>; <a href="#CD011785-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD011785-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011785-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD011785-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011785-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD011785-sec-0081"> <h4 class="title">Allocation</h4> <p>Allocation methods were not adequately reported for 10 trials so these trials were at unclear risk of selection bias (<a href="./references#CD011785-bbs2-0001" title="DengHL , LongJH , MoK . Investigation of the effects of Omeprazole therapy on neonates with upper gastrointestinal hemorrhage. Hebei Medicine2005;11(8):723‐5. ">Deng 2005</a>; <a href="./references#CD011785-bbs2-0002" title="HanM , YeXQ , YuanJQ . Cimetidine in prevention of acute gastric mucosal lesion of newborns. Journal of Bengbu Medical College2001;26(4):315‐6. ">Han 2001</a>; <a href="./references#CD011785-bbs2-0003" title="HuoK . Cimetidine in treating upper alimentary canal hemorrhage after critical neonates in 42 cases. Journal of Pediatric Pharmacy2001;7(3):25‐6. ">Huo 2001</a>; <a href="./references#CD011785-bbs2-0004" title="KuuselaAL , RuuskaT , KarikoskiR , LaippalaP , IkonenRS , JanasM , et al. A randomized, controlled study of prophylactic ranitidine in preventing stress‐induced gastric mucosal lesions in neonatal intensive care unit patients. Critical Care Medicine1997;25(2):346‐51. [PUBMED: 9034275] ">Kuusela 1997</a>; <a href="./references#CD011785-bbs2-0005" title="LinXY . The efficacy of stomach injection method applied stress ulcer omeprazole treatment of neonatal. China Practical Medicine2011;6(32):14‐5. ">Lin 2011</a>; <a href="./references#CD011785-bbs2-0006" title="LiuH . Observations of effect of Famotidine on hemorrhage of digestive tract in newborn. China Journal of Modern Medicine2005;15(12):1870‐1, 4. ">Liu 2005</a>; <a href="./references#CD011785-bbs2-0007" title="LuWQ . The effect of cimetidine in preventing from acute gastric mucosal lesion of neonates. Journal of Neonatology1995;10(1):23‐4. ">Lu 1995</a>; <a href="./references#CD011785-bbs2-0008" title="PourarianS , ImaniB , ImaniehMH . Prophylactic ranitidine in prevention of GI bleeding in neonatal intensive care units. Iranian Journal of Medical Sciences2005;30(4):178‐81. ">Pourarian 2005</a>; <a href="./references#CD011785-bbs2-0010" title="YangJ , ZhaoQM , ZhangY . Ranitidine and smecta in treatment of neonates with upper gastrointestinal hemorrhage. Journal of Pediatric Pharmacy2004;10(2):38‐9. ">Yang 2004</a>; <a href="./references#CD011785-bbs2-0011" title="YangD . The efficacy observation of Omeprazole in treatment of neonatal stress ulcer. China Health Standard Management2015;6(7):221‐2. ">Yang 2015</a>); and one trial reported alternately allocating infants to intervention so was at high risk of selection bias (<a href="./references#CD011785-bbs2-0009" title="SarnaMS , SailiA , DuttaAK , SharmaD . Stress associated gastric bleeding in newborn‐‐role of ranitidine. Indian Pediatrics1991;28(11):1305‐8. [PUBMED: 1808052] ">Sarna 1991</a>). </p> </section> <section id="CD011785-sec-0082"> <h4 class="title">Blinding</h4> <p>No trial reported blinding of intervention or measurement, so all trials were at unclear risk of performance bias and detection bias. </p> </section> <section id="CD011785-sec-0083"> <h4 class="title">Incomplete outcome data</h4> <p>Nine studies were at low risk of attrition bias (<a href="./references#CD011785-bbs2-0001" title="DengHL , LongJH , MoK . Investigation of the effects of Omeprazole therapy on neonates with upper gastrointestinal hemorrhage. Hebei Medicine2005;11(8):723‐5. ">Deng 2005</a>; <a href="./references#CD011785-bbs2-0002" title="HanM , YeXQ , YuanJQ . Cimetidine in prevention of acute gastric mucosal lesion of newborns. Journal of Bengbu Medical College2001;26(4):315‐6. ">Han 2001</a>; <a href="./references#CD011785-bbs2-0003" title="HuoK . Cimetidine in treating upper alimentary canal hemorrhage after critical neonates in 42 cases. Journal of Pediatric Pharmacy2001;7(3):25‐6. ">Huo 2001</a>; <a href="./references#CD011785-bbs2-0004" title="KuuselaAL , RuuskaT , KarikoskiR , LaippalaP , IkonenRS , JanasM , et al. A randomized, controlled study of prophylactic ranitidine in preventing stress‐induced gastric mucosal lesions in neonatal intensive care unit patients. Critical Care Medicine1997;25(2):346‐51. [PUBMED: 9034275] ">Kuusela 1997</a>; <a href="./references#CD011785-bbs2-0005" title="LinXY . The efficacy of stomach injection method applied stress ulcer omeprazole treatment of neonatal. China Practical Medicine2011;6(32):14‐5. ">Lin 2011</a>; <a href="./references#CD011785-bbs2-0006" title="LiuH . Observations of effect of Famotidine on hemorrhage of digestive tract in newborn. China Journal of Modern Medicine2005;15(12):1870‐1, 4. ">Liu 2005</a>; <a href="./references#CD011785-bbs2-0007" title="LuWQ . The effect of cimetidine in preventing from acute gastric mucosal lesion of neonates. Journal of Neonatology1995;10(1):23‐4. ">Lu 1995</a>; <a href="./references#CD011785-bbs2-0009" title="SarnaMS , SailiA , DuttaAK , SharmaD . Stress associated gastric bleeding in newborn‐‐role of ranitidine. Indian Pediatrics1991;28(11):1305‐8. [PUBMED: 1808052] ">Sarna 1991</a>; <a href="./references#CD011785-bbs2-0011" title="YangD . The efficacy observation of Omeprazole in treatment of neonatal stress ulcer. China Health Standard Management2015;6(7):221‐2. ">Yang 2015</a>). <a href="./references#CD011785-bbs2-0010" title="YangJ , ZhaoQM , ZhangY . Ranitidine and smecta in treatment of neonates with upper gastrointestinal hemorrhage. Journal of Pediatric Pharmacy2004;10(2):38‐9. ">Yang 2004</a> reported post‐randomisation losses due to haemorrhagic diseases and adverse effects of medication. </p> </section> <section id="CD011785-sec-0084"> <h4 class="title">Selective reporting</h4> <p>The protocols were unavailable for all studies so risk of reporting bias was unclear for all studies. </p> </section> <section id="CD011785-sec-0085"> <h4 class="title">Other potential sources of bias</h4> <p>No other potential sources of bias were found for eight trials (<a href="./references#CD011785-bbs2-0002" title="HanM , YeXQ , YuanJQ . Cimetidine in prevention of acute gastric mucosal lesion of newborns. Journal of Bengbu Medical College2001;26(4):315‐6. ">Han 2001</a>; <a href="./references#CD011785-bbs2-0003" title="HuoK . Cimetidine in treating upper alimentary canal hemorrhage after critical neonates in 42 cases. Journal of Pediatric Pharmacy2001;7(3):25‐6. ">Huo 2001</a>; <a href="./references#CD011785-bbs2-0004" title="KuuselaAL , RuuskaT , KarikoskiR , LaippalaP , IkonenRS , JanasM , et al. A randomized, controlled study of prophylactic ranitidine in preventing stress‐induced gastric mucosal lesions in neonatal intensive care unit patients. Critical Care Medicine1997;25(2):346‐51. [PUBMED: 9034275] ">Kuusela 1997</a>; <a href="./references#CD011785-bbs2-0005" title="LinXY . The efficacy of stomach injection method applied stress ulcer omeprazole treatment of neonatal. China Practical Medicine2011;6(32):14‐5. ">Lin 2011</a>; <a href="./references#CD011785-bbs2-0006" title="LiuH . Observations of effect of Famotidine on hemorrhage of digestive tract in newborn. China Journal of Modern Medicine2005;15(12):1870‐1, 4. ">Liu 2005</a>; <a href="./references#CD011785-bbs2-0007" title="LuWQ . The effect of cimetidine in preventing from acute gastric mucosal lesion of neonates. Journal of Neonatology1995;10(1):23‐4. ">Lu 1995</a>; <a href="./references#CD011785-bbs2-0009" title="SarnaMS , SailiA , DuttaAK , SharmaD . Stress associated gastric bleeding in newborn‐‐role of ranitidine. Indian Pediatrics1991;28(11):1305‐8. [PUBMED: 1808052] ">Sarna 1991</a>; <a href="./references#CD011785-bbs2-0011" title="YangD . The efficacy observation of Omeprazole in treatment of neonatal stress ulcer. China Health Standard Management2015;6(7):221‐2. ">Yang 2015</a>). For three trials this was unclear. <a href="./references#CD011785-bbs2-0001" title="DengHL , LongJH , MoK . Investigation of the effects of Omeprazole therapy on neonates with upper gastrointestinal hemorrhage. Hebei Medicine2005;11(8):723‐5. ">Deng 2005</a> did not report baseline characteristics; <a href="./references#CD011785-bbs2-0008" title="PourarianS , ImaniB , ImaniehMH . Prophylactic ranitidine in prevention of GI bleeding in neonatal intensive care units. Iranian Journal of Medical Sciences2005;30(4):178‐81. ">Pourarian 2005</a> reported some baseline differences between groups; and <a href="./references#CD011785-bbs2-0010" title="YangJ , ZhaoQM , ZhangY . Ranitidine and smecta in treatment of neonates with upper gastrointestinal hemorrhage. Journal of Pediatric Pharmacy2004;10(2):38‐9. ">Yang 2004</a> had an imbalance in numbers between groups. </p> </section> </section> <section id="CD011785-sec-0086"> <h3 class="title" id="CD011785-sec-0086">Effects of interventions</h3> <p>See: <a href="./full#CD011785-tbl-0001"><b>Summary of findings for the main comparison</b> Prevention of upper gastrointestinal bleeding in newborn infants</a>; <a href="./full#CD011785-tbl-0002"><b>Summary of findings 2</b> Treatment of upper gastrointestinal bleeding in newborn infants</a> </p> <section id="CD011785-sec-0087"> <h4 class="title">Comparison 1: Prevention of upper gastrointestinal bleeding</h4> <section id="CD011785-sec-0088"> <h5 class="title">Primary outcomes</h5> <p>Mortality (<a href="./references#CD011785-fig-0004" title="">Analysis 1.1</a>): <a href="./references#CD011785-bbs2-0004" title="KuuselaAL , RuuskaT , KarikoskiR , LaippalaP , IkonenRS , JanasM , et al. A randomized, controlled study of prophylactic ranitidine in preventing stress‐induced gastric mucosal lesions in neonatal intensive care unit patients. Critical Care Medicine1997;25(2):346‐51. [PUBMED: 9034275] ">Kuusela 1997</a> reported no difference in mortality (RR 2.42, 95% CI 0.70 to 8.38; participants = 53). We downgraded the quality of evidence to very low due to risk of bias and very serious imprecision (single small study comparing ranitidine versus no treatment). </p> <p>Any upper gastrointestinal bleeding in infants at risk of upper gastrointestinal bleeding (<a href="./references#CD011785-fig-0005" title="">Analysis 1.2</a>): our meta‐analysis showed a reduction in any upper gastrointestinal bleeding from use of H2RA compared to no treatment (RR 0.36, 95% CI 0.22 to 0.58; participants = 329; studies = 4; I² = 0%). We downgraded the quality of evidence to moderate due to risk of bias. </p> </section> <section id="CD011785-sec-0089"> <h5 class="title">Secondary outcomes</h5> <p>Gastric lesions detected by endoscopy and macroscopically (<a href="./references#CD011785-fig-0006" title="">Analysis 1.3</a>): <a href="./references#CD011785-bbs2-0004" title="KuuselaAL , RuuskaT , KarikoskiR , LaippalaP , IkonenRS , JanasM , et al. A randomized, controlled study of prophylactic ranitidine in preventing stress‐induced gastric mucosal lesions in neonatal intensive care unit patients. Critical Care Medicine1997;25(2):346‐51. [PUBMED: 9034275] ">Kuusela 1997</a> reported a reduction in gastric lesions detected by endoscopy from use of an H2RA compared to no treatment (RR 0.49, 95% CI 0.28 to 0.84; participants = 48). </p> <p>Serious adverse reactions (<a href="./references#CD011785-fig-0007" title="">Analysis 1.4</a>): no serious adverse reactions were reported from use of an H2RA (participants = 329; studies = 4). </p> <p>No data were available from included trials that assessed other secondary outcomes.</p> </section> </section> <section id="CD011785-sec-0090"> <h4 class="title">Comparison 2: Treatment of upper gastrointestinal bleeding</h4> <section id="CD011785-sec-0091"> <h5 class="title">Primary outcomes</h5> <p>Mortality (<a href="./references#CD011785-fig-0008" title="">Analysis 2.1</a>): our meta‐analysis showed no significant difference in mortality from use of an H2RA compared to no treatment (typical RR 0.63, 95% CI 0.26 to 1.51; participants = 131; studies = 2; I² = 0%), although the quality of evidence was low. The clinical significance of this result was unclear. </p> <p>Duration of upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding (days) (<a href="./references#CD011785-fig-0009" title="">Analysis 2.2</a>): our meta‐analysis showed a reduction in duration of upper gastrointestinal bleeding from use of an inhibitor of gastric acid (PPI or H2RA) compared to no treatment (MD −1.06, 95% CI −1.28 to −0.84; participants = 104; studies = 2; I² = 63%). We downgraded the quality of evidence to very low due to risk of bias, inconsistency and imprecision. <a href="./references#CD011785-bbs2-0001" title="DengHL , LongJH , MoK . Investigation of the effects of Omeprazole therapy on neonates with upper gastrointestinal hemorrhage. Hebei Medicine2005;11(8):723‐5. ">Deng 2005</a> reported a reduction in duration of upper gastrointestinal bleeding from use of a PPI compared to no treatment (MD −1.06, 95% CI −1.28 to −0.84; participants = 66). <a href="./references#CD011785-bbs2-0009" title="SarnaMS , SailiA , DuttaAK , SharmaD . Stress associated gastric bleeding in newborn‐‐role of ranitidine. Indian Pediatrics1991;28(11):1305‐8. [PUBMED: 1808052] ">Sarna 1991</a> reported no significant difference in duration of upper gastrointestinal bleeding from use of an H2RA compared to no treatment (MD −9.50, 95% CI −19.55 to 0.55; participants = 38). The test for subgroup differences was not significant (P = 0.10; I² = 63.0%). </p> <p>Continued upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding at latest time reported (<a href="./references#CD011785-fig-0010" title="">Analysis 2.3</a>): our meta‐analysis showed a reduction in continued upper gastrointestinal bleeding from use of any inhibitor of gastric acid compared to no treatment (typical RR 0.36, 95% CI 0.26 to 0.49; participants = 451; studies = 6; I² = 63%). Heterogeneity was moderate. The quality of evidence was downgraded to low quality due to risk of bias and imprecision. Our meta‐analysis showed a reduction in continued upper gastrointestinal bleeding from use of a PPI compared to no treatment (typical RR 0.39, 95% CI 0.27 to 0.57; participants = 263; studies = 3; I² = 80%). Heterogeneity was high. Our meta‐analysis showed a reduction in continued upper gastrointestinal bleeding from use of an H2RA compared to no treatment (typical RR 0.30, 95% CI 0.17 to 0.54; participants = 188; studies = 3; I² = 0%). The test for subgroup differences was not significant (P = 0.45; I² = 0%). </p> </section> <section id="CD011785-sec-0092"> <h5 class="title">Secondary outcomes</h5> <p>Anaemia requiring blood transfusion (<a href="./references#CD011785-fig-0011" title="">Analysis 2.4</a>): <a href="./references#CD011785-bbs2-0009" title="SarnaMS , SailiA , DuttaAK , SharmaD . Stress associated gastric bleeding in newborn‐‐role of ranitidine. Indian Pediatrics1991;28(11):1305‐8. [PUBMED: 1808052] ">Sarna 1991</a> reported no difference in anaemia requiring blood transfusion from use of an H2RA compared to no treatment (RR 0.60, 95% CI 0.11 to 3.19; participants = 38). We downgraded the quality of evidence to low due to risk of bias and imprecision. </p> <p>Serious adverse reactions (<a href="./references#CD011785-fig-0012" title="">Analysis 2.5</a>): no studies of a PPI reported serious adverse reactions. No serious adverse reactions were reported from use of an H2RA (participants = 226; studies = 3). </p> <p>No data were available from included trials that assessed other secondary outcomes.</p> </section> </section> <section id="CD011785-sec-0093"> <h4 class="title">Subgroup analyses</h4> <p>We could not report most prespecified subgroup analyses. Four trials enrolled infants at high risk of gastrointestinal bleeding with the goal of preventing gastrointestinal haemorrhage (<a href="./references#CD011785-bbs2-0002" title="HanM , YeXQ , YuanJQ . Cimetidine in prevention of acute gastric mucosal lesion of newborns. Journal of Bengbu Medical College2001;26(4):315‐6. ">Han 2001</a>; <a href="./references#CD011785-bbs2-0004" title="KuuselaAL , RuuskaT , KarikoskiR , LaippalaP , IkonenRS , JanasM , et al. A randomized, controlled study of prophylactic ranitidine in preventing stress‐induced gastric mucosal lesions in neonatal intensive care unit patients. Critical Care Medicine1997;25(2):346‐51. [PUBMED: 9034275] ">Kuusela 1997</a>; <a href="./references#CD011785-bbs2-0007" title="LuWQ . The effect of cimetidine in preventing from acute gastric mucosal lesion of neonates. Journal of Neonatology1995;10(1):23‐4. ">Lu 1995</a>; <a href="./references#CD011785-bbs2-0008" title="PourarianS , ImaniB , ImaniehMH . Prophylactic ranitidine in prevention of GI bleeding in neonatal intensive care units. Iranian Journal of Medical Sciences2005;30(4):178‐81. ">Pourarian 2005</a>). The criteria for enrolment included term and preterm newborns with severe illness (<a href="./references#CD011785-bbs2-0002" title="HanM , YeXQ , YuanJQ . Cimetidine in prevention of acute gastric mucosal lesion of newborns. Journal of Bengbu Medical College2001;26(4):315‐6. ">Han 2001</a>; <a href="./references#CD011785-bbs2-0007" title="LuWQ . The effect of cimetidine in preventing from acute gastric mucosal lesion of neonates. Journal of Neonatology1995;10(1):23‐4. ">Lu 1995</a>); newborns commencing mechanical ventilation in the first two days (<a href="./references#CD011785-bbs2-0004" title="KuuselaAL , RuuskaT , KarikoskiR , LaippalaP , IkonenRS , JanasM , et al. A randomized, controlled study of prophylactic ranitidine in preventing stress‐induced gastric mucosal lesions in neonatal intensive care unit patients. Critical Care Medicine1997;25(2):346‐51. [PUBMED: 9034275] ">Kuusela 1997</a>); and term and preterm newborns admitted to NICU (<a href="./references#CD011785-bbs2-0008" title="PourarianS , ImaniB , ImaniehMH . Prophylactic ranitidine in prevention of GI bleeding in neonatal intensive care units. Iranian Journal of Medical Sciences2005;30(4):178‐81. ">Pourarian 2005</a>). </p> <p>Seven trials enrolled infants with active gastrointestinal bleeding (<a href="./references#CD011785-bbs2-0001" title="DengHL , LongJH , MoK . Investigation of the effects of Omeprazole therapy on neonates with upper gastrointestinal hemorrhage. Hebei Medicine2005;11(8):723‐5. ">Deng 2005</a>; <a href="./references#CD011785-bbs2-0003" title="HuoK . Cimetidine in treating upper alimentary canal hemorrhage after critical neonates in 42 cases. Journal of Pediatric Pharmacy2001;7(3):25‐6. ">Huo 2001</a>; <a href="./references#CD011785-bbs2-0005" title="LinXY . The efficacy of stomach injection method applied stress ulcer omeprazole treatment of neonatal. China Practical Medicine2011;6(32):14‐5. ">Lin 2011</a>; <a href="./references#CD011785-bbs2-0006" title="LiuH . Observations of effect of Famotidine on hemorrhage of digestive tract in newborn. China Journal of Modern Medicine2005;15(12):1870‐1, 4. ">Liu 2005</a>; <a href="./references#CD011785-bbs2-0009" title="SarnaMS , SailiA , DuttaAK , SharmaD . Stress associated gastric bleeding in newborn‐‐role of ranitidine. Indian Pediatrics1991;28(11):1305‐8. [PUBMED: 1808052] ">Sarna 1991</a>; <a href="./references#CD011785-bbs2-0010" title="YangJ , ZhaoQM , ZhangY . Ranitidine and smecta in treatment of neonates with upper gastrointestinal hemorrhage. Journal of Pediatric Pharmacy2004;10(2):38‐9. ">Yang 2004</a>; <a href="./references#CD011785-bbs2-0011" title="YangD . The efficacy observation of Omeprazole in treatment of neonatal stress ulcer. China Health Standard Management2015;6(7):221‐2. ">Yang 2015</a>). Five studies reported enrolling term and preterm newborns with severe illness (<a href="./references#CD011785-bbs2-0003" title="HuoK . Cimetidine in treating upper alimentary canal hemorrhage after critical neonates in 42 cases. Journal of Pediatric Pharmacy2001;7(3):25‐6. ">Huo 2001</a>; <a href="./references#CD011785-bbs2-0005" title="LinXY . The efficacy of stomach injection method applied stress ulcer omeprazole treatment of neonatal. China Practical Medicine2011;6(32):14‐5. ">Lin 2011</a>; <a href="./references#CD011785-bbs2-0006" title="LiuH . Observations of effect of Famotidine on hemorrhage of digestive tract in newborn. China Journal of Modern Medicine2005;15(12):1870‐1, 4. ">Liu 2005</a>; <a href="./references#CD011785-bbs2-0010" title="YangJ , ZhaoQM , ZhangY . Ranitidine and smecta in treatment of neonates with upper gastrointestinal hemorrhage. Journal of Pediatric Pharmacy2004;10(2):38‐9. ">Yang 2004</a>; <a href="./references#CD011785-bbs2-0011" title="YangD . The efficacy observation of Omeprazole in treatment of neonatal stress ulcer. China Health Standard Management2015;6(7):221‐2. ">Yang 2015</a>); whilst two studies did not report illness severity (<a href="./references#CD011785-bbs2-0001" title="DengHL , LongJH , MoK . Investigation of the effects of Omeprazole therapy on neonates with upper gastrointestinal hemorrhage. Hebei Medicine2005;11(8):723‐5. ">Deng 2005</a>; <a href="./references#CD011785-bbs2-0009" title="SarnaMS , SailiA , DuttaAK , SharmaD . Stress associated gastric bleeding in newborn‐‐role of ranitidine. Indian Pediatrics1991;28(11):1305‐8. [PUBMED: 1808052] ">Sarna 1991</a>). </p> <p>We could not extract data separately for the following subgroup analyses: preterm and term gestation infants; according to weight for age z‐score; and risk factor present for the development of upper gastrointestinal bleeding. However, the majority of studies included sick term and preterm infants. </p> <section id="CD011785-sec-0094"> <h5 class="title">Higher versus lower dose of pharmacological intervention (median dosing recommendation as the threshold) </h5> <section id="CD011785-sec-0095"> <h6 class="title">Primary outcomes</h6> <p>Mortality (<a href="./references#CD011785-fig-0013" title="">Analysis 3.1</a>): <a href="./references#CD011785-bbs2-0003" title="HuoK . Cimetidine in treating upper alimentary canal hemorrhage after critical neonates in 42 cases. Journal of Pediatric Pharmacy2001;7(3):25‐6. ">Huo 2001</a> reported no significant difference in mortality from use of higher dose H2RA (cimetidine) compared to no treatment (RR 0.59, 95% CI 0.15 to 2.29; participants = 83). <a href="./references#CD011785-bbs2-0009" title="SarnaMS , SailiA , DuttaAK , SharmaD . Stress associated gastric bleeding in newborn‐‐role of ranitidine. Indian Pediatrics1991;28(11):1305‐8. [PUBMED: 1808052] ">Sarna 1991</a> reported no significant difference in mortality from use of lower dose H2RA (raniditine) compared to no treatment (RR 0.67, 95% CI 0.22 to 2.07; participants = 48). Test for subgroup differences was not significant (P = 0.89; I² = 0%). </p> <p>Duration of upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding (days) (<a href="./references#CD011785-fig-0014" title="">Analysis 3.2</a>): <a href="./references#CD011785-bbs2-0001" title="DengHL , LongJH , MoK . Investigation of the effects of Omeprazole therapy on neonates with upper gastrointestinal hemorrhage. Hebei Medicine2005;11(8):723‐5. ">Deng 2005</a> reported a reduction in duration of upper gastrointestinal bleeding from use of higher dose PPI (omeprazole) compared to no treatment (MD −1.06, 95% CI −1.28 to −0.84; participants = 66). <a href="./references#CD011785-bbs2-0009" title="SarnaMS , SailiA , DuttaAK , SharmaD . Stress associated gastric bleeding in newborn‐‐role of ranitidine. Indian Pediatrics1991;28(11):1305‐8. [PUBMED: 1808052] ">Sarna 1991</a> reported no significant difference in duration of upper gastrointestinal bleeding from use of lower dose H2RA (ranitidine) compared to no treatment (MD −9.50, 95% CI −19.55 to 0.55; participants = 38). Test for subgroup differences was not significant (P = 0.10; I² = 63.0%). </p> <p>Continued upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding at latest time reported (<a href="./references#CD011785-fig-0015" title="">Analysis 3.3</a>): our meta‐analysis showed a reduction in continued upper gastrointestinal bleeding from use of higher dose inhibitor of gastric acid compared to no treatment (RR 0.46, 95% CI 0.33 to 0.64; participants = 207; studies = 3; I² = 53%). Heterogeneity was moderate. Our meta‐analysis showed a reduction in continued upper gastrointestinal bleeding from use of lower dose inhibitor of gastric acid compared to no treatment (RR 0.19, 95% CI 0.09 to 0.42; participants = 244; studies = 3; I² = 50%). Heterogeneity was moderate. The test for subgroup differences was significant (P = 0.05; I² = 74.9%). </p> </section> </section> </section> <section id="CD011785-sec-0096"> <h4 class="title">Sensitivity analyses</h4> <p>We assessed no studies as being at low risk of bias with regard to adequate allocation concealment, randomisation, blinding of treatment and less than 10% loss to follow‐up. However, for the majority of studies the criteria for bias were unclear due to a failure to report details. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011785-sec-0097" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011785-sec-0097"></div> <section id="CD011785-sec-0098"> <h3 class="title" id="CD011785-sec-0098">Summary of main results</h3> <section id="CD011785-sec-0099"> <h4 class="title">Prevention of upper gastrointestinal bleeding</h4> <p>A single trial with 53 infants reported no difference in mortality from use of an H2RA compared to no treatment. We graded the quality of evidence as very low with downgrading due to risk of bias and very serious imprecision. Meta‐analysis of four trials with 329 infants found a reduction in any upper gastrointestinal bleeding from use of H2RA compared to no treatment (typical risk difference (RD) −0.20, 95% CI −0.28 to −0.11; NNTB 5, 95% CI 4 to 9). We graded the quality of evidence as moderate with downgrading due to risk of bias. For secondary outcomes, our review found a single study reporting a reduction in gastric lesions detected by endoscopy from use of an H2RA compared to no treatment. Four trials with 329 infants reported no serious adverse reactions from use of an H2RA compared to no treatment. No study reported the incidence of necrotising enterocolitis, ventilator‐ or hospital‐associated pneumonia, sepsis, or long‐term outcome. </p> </section> <section id="CD011785-sec-0100"> <h4 class="title">Treatment of upper gastrointestinal bleeding</h4> <p>Meta‐analysis of two trials including 131 infants found no significant difference in mortality from use of an H2RA compared to no treatment for treatment of gastrointestinal bleeding. We graded the quality of evidence as low, with downgrading due to risk of bias and imprecision. Meta‐analysis of two trials including 104 infants found a reduction in duration of upper gastrointestinal bleeding from use of any inhibitor of gastric acid compared to no treatment (MD −1.06 days, 95% CI −1.28 to −0.84). Meta‐analysis of six trials including 451 infants showed a reduction in continued upper gastrointestinal bleeding from use of any inhibitor of gastric acid compared to no treatment (typical RD −0.26, 95% CI −0.33, −0.19; NNTB 4, 95% CI 3 to 5). No study reported the incidence of necrotising enterocolitis, ventilator‐ or hospital‐associated pneumonia, sepsis, or long‐term outcome. There were no significant subgroup differences in duration of upper gastrointestinal bleeding or of continued upper gastrointestinal bleeding according to type of inhibitor of gastric acid (PPI versus H2RA). Data regarding adverse effects are limited. A single trial with 38 infants reported no difference in anaemia requiring blood transfusion from use of an H2RA compared to no treatment. No studies of a PPI reported serious adverse reactions. Three trials including 226 infants reported no serious adverse reactions from use of an H2RA. </p> <p>A subgroup analysis of higher versus lower doses of inhibitor of gastric acid did not identify any significant subgroup differences for mortality or duration of upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding. Although an analysis of continued upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding found a significant subgroup difference between higher versus lower dose trials, the greatest effect was in the lower dose group. This review found no evidence that use of higher doses of inhibitor of gastric acid results in a further reduction in gastrointestinal bleeding in newborn infants. </p> </section> </section> <section id="CD011785-sec-0101"> <h3 class="title" id="CD011785-sec-0101">Overall completeness and applicability of evidence</h3> <p>The trials included in this review enrolled term and preterm infants at high risk of gastrointestinal bleeding on the basis of illness severity or need for NICU and mechanical ventilation, or infants with gastrointestinal bleeding, most commonly due to concomitant illness. The evidence is most likely to be applicable to sick term and near‐term infants at high risk of gastrointestinal bleeding or with active bleeding. Several trials excluded infants with abnormal bleeding times or clotting (<a href="./references#CD011785-bbs2-0002" title="HanM , YeXQ , YuanJQ . Cimetidine in prevention of acute gastric mucosal lesion of newborns. Journal of Bengbu Medical College2001;26(4):315‐6. ">Han 2001</a>; <a href="./references#CD011785-bbs2-0006" title="LiuH . Observations of effect of Famotidine on hemorrhage of digestive tract in newborn. China Journal of Modern Medicine2005;15(12):1870‐1, 4. ">Liu 2005</a>; <a href="./references#CD011785-bbs2-0008" title="PourarianS , ImaniB , ImaniehMH . Prophylactic ranitidine in prevention of GI bleeding in neonatal intensive care units. Iranian Journal of Medical Sciences2005;30(4):178‐81. ">Pourarian 2005</a>; <a href="./references#CD011785-bbs2-0009" title="SarnaMS , SailiA , DuttaAK , SharmaD . Stress associated gastric bleeding in newborn‐‐role of ranitidine. Indian Pediatrics1991;28(11):1305‐8. [PUBMED: 1808052] ">Sarna 1991</a>; <a href="./references#CD011785-bbs2-0010" title="YangJ , ZhaoQM , ZhangY . Ranitidine and smecta in treatment of neonates with upper gastrointestinal hemorrhage. Journal of Pediatric Pharmacy2004;10(2):38‐9. ">Yang 2004</a>). It is unclear if treatment with an inhibitor of gastric acid is effective in infants with these disorders. </p> <p>The trials addressed the effects of a single PPI, omeprazole, for treatment of upper gastrointestinal bleeding, and H2RAs including cimetidine, famotidine and ranitidine for the prevention and treatment of upper gastrointestinal bleeding. Studies of H2RA gave cimetidine, famotidine or ranitidine intravenously until bleeding ceased. Studies of PPI gave omeprazole via the intragastric tube. One trial of ranitidine also used Smecta (a natural silicate of aluminium and magnesium) in the treatment group (<a href="./references#CD011785-bbs2-0010" title="YangJ , ZhaoQM , ZhangY . Ranitidine and smecta in treatment of neonates with upper gastrointestinal hemorrhage. Journal of Pediatric Pharmacy2004;10(2):38‐9. ">Yang 2004</a>); and another trial of omeprazole orally also reported usual treatment in both groups consisting of nil by mouth and bicarbonate (HCO₃) stomach wash (<a href="./references#CD011785-bbs2-0005" title="LinXY . The efficacy of stomach injection method applied stress ulcer omeprazole treatment of neonatal. China Practical Medicine2011;6(32):14‐5. ">Lin 2011</a>). There was no trial in newborn infants that reported the use of sucralfate. </p> <p>Few studies reported mortality so the analysis is substantially underpowered. Studies consistently reported H2RA prevented gastrointestinal bleeding in high‐risk infants, and both H2RAs and PPIs reduced duration of gastrointestinal bleeding and continued gastrointestinal bleeding in infants with gastrointestinal bleeding. A single study reported no effect on anaemia requiring blood transfusion. </p> <p>Other important neonatal morbidities including necrotising enterocolitis, ventilator‐associated pneumonia, duration of ventilation and respiratory support, and duration of hospital stay were not reported. Long‐term outcomes have not been reported. We could not perform subgroup analyses according to gestation age, weight for age z‐score and risk factor for development of upper gastrointestinal bleeding. However, the trials in this review predominately enrolled term or near‐term infants who were sick, required mechanical ventilation, or had upper gastrointestinal bleeding. </p> </section> <section id="CD011785-sec-0102"> <h3 class="title" id="CD011785-sec-0102">Quality of the evidence</h3> <p>For prevention of upper gastrointestinal bleeding in newborn infants, we assessed the quality of evidence for mortality as very low, with downgrading due to risk of bias and very serious imprecision. The quality of evidence for any upper gastrointestinal bleeding was assessed as moderate, with downgrading due to risk of bias. The analyses had narrow confidence intervals and we found no heterogeneity between studies. All studies compared H2RA versus no treatment. See <a href="./full#CD011785-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>For treatment of upper gastrointestinal bleeding in newborn infants, we assessed the quality of evidence for mortality as low with downgrading due to risk of bias and imprecision. Both studies compared H2RA versus no treatment. We assessed the quality of evidence for duration of upper gastrointestinal bleeding as very low with downgrading due to risk of bias, inconsistency and imprecision. One study compared PPI versus no treatment; and one study compared H2RA versus no treatment. We found no significant subgroup difference. We assessed the quality of evidence for continued upper gastrointestinal bleeding as low, with downgrading due to risk of bias and imprecision. Three studies compared PPI versus no treatment and three studies compared H2RA versus no treatment. No significant subgroup difference was found. We assessed the quality of evidence for anaemia requiring blood transfusion as low, with downgrading due to risk of bias and imprecision. A single small study compared ranitidine versus no treatment. </p> <p>Ten of the 11 trials included in this review did not report methods of sequence generation, allocation concealment, use of a placebo or attempts to blind participants, personnel or outcome assessment. The majority of these are published in Chinese language journals. It is unclear if this reflects a concern about potential for bias in the included studies or simply relates to reporting standards in Chinese language journals. </p> </section> <section id="CD011785-sec-0103"> <h3 class="title" id="CD011785-sec-0103">Potential biases in the review process</h3> <p>We undertook an extensive literature search for published and unpublished studies including non‐English publications. We found a substantial number of Chinese language articles and they were translated by one of the authors (KL). It is unclear whether the search tools used identified all Chinese language studies. </p> <p>The review used standard Cochrane methodology with a pre‐published protocol. We prespecified comparisons and outcomes. We added a single outcome post hoc: serious adverse reactions. Two independent reviewers cross‐checked eligibility, risk of bias and data extraction. We used Google Translate to cross‐check Chinese language articles. </p> <p>As assessments of risk of bias in this review are substantially affected by the under‐reporting of methodology (including methods of sequence generation, allocation concealment, use of a placebo or attempts to blind participants, personnel or outcome assessment), this review has the potential to under‐ or over‐report the quality of evidence. </p> </section> <section id="CD011785-sec-0104"> <h3 class="title" id="CD011785-sec-0104">Agreements and disagreements with other studies or reviews</h3> <p>Stress ulcer prophylaxis has been a standard of care in intensive care patients (<a href="./references#CD011785-bbs2-0071" title="EastwoodGM , LittonE , BellomoR , BaileyMJ , FestaM , BeasleyRW , YoungPJ . Opinions and practice of stress ulcer prophylaxis in Australian and New Zealand intensive care units. Critical Care and Resuscitation2014;16(3):170‐4. [PUBMED: 25161018] ">Eastwood 2014</a>; <a href="./references#CD011785-bbs2-0079" title="KragM , PernerA , WetterslevJ , WiseMP , BorthwickM , BendelS , et al. Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries. Acta Anaesthesiologica Scandinavica2015;59:576‐85. [DOI: 10.1111/aas.12508; PUBMED: 25880349 ] ">Krag 2015</a>; <a href="./references#CD011785-bbs2-0081" title="LamNP , LePD , CrawfordSY , PatelS . National survey of stress ulcer prophylaxis. Critical Care Medicine1999;27(1):98‐103. [PUBMED: 9934901] ">Lam 1999</a>; <a href="./references#CD011785-bbs2-0100" title="ShearsM , AlhazzaniW , MarshallJC , MuscedereJ , HallR , EnglishSW , et al. Stress ulcer prophylaxis in critical illness: a Canadian survey. Canadian Journal of Anaesthesia2016;63(6):718‐24. [DOI: 10.1007/s12630‐016‐0612‐3; PUBMED: 26911559] ">Shears 2016</a>). Stress ulcer prophylaxis is also commonly used in paediatric intensive care patients (<a href="./references#CD011785-bbs2-0060" title="AraujoTE , VieiraSM , CarvalhoPR . Stress ulcer prophylaxis in pediatric intensive care units. Jornal de Pediatria2010;86(6):525‐30. [DOI: doi:10.2223/JPED.2046; PUBMED: 21140039] ">Araujo 2010</a>; <a href="./references#CD011785-bbs2-0070" title="CostarinoAT , DaiD , FengR , FeudtnerC , GuevaraJP . Gastric acid suppressant prophylaxis in pediatric intensive care: current practice as reflected in a large administrative database. Pediatric Critical Care Medicine2015;16(7):605‐12. [DOI: 10.1097/PCC.0000000000000427; PUBMED: 25901549] ">Costarino 2015</a>). However, recent systematic reviews and meta‐analyses have failed to find conclusive evidence that use of H2RAs or PPIs in intensive care patients reduced gastrointestinal bleeding without increasing the incidence of ventilator‐ or hospital‐associated pneumonia (<a href="./references#CD011785-bbs2-0058" title="AlhazzaniW , GuyattG , AlshahraniM , DeaneAM , MarshallJC , HallR , et al. Withholding pantoprazole for stress ulcer prophylaxis in critically ill patients: a pilot randomized clinical trial and meta‐analysis. Critical Care Medicine2017;45(7):1121‐9. [DOI: 10.1097/CCM.0000000000002461; PUBMED: 28459708] ">Alhazzani 2017</a>; <a href="./references#CD011785-bbs2-0079" title="KragM , PernerA , WetterslevJ , WiseMP , BorthwickM , BendelS , et al. Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries. Acta Anaesthesiologica Scandinavica2015;59:576‐85. [DOI: 10.1111/aas.12508; PUBMED: 25880349 ] ">Krag 2015</a>; <a href="./references#CD011785-bbs2-0088" title="MarikPE , VasuT , HiraniA , PachinburavanM . Stress ulcer prophylaxis in the new millennium: a systematic review and meta‐analysis. Critical Care Medicine2010;38(11):2222‐8. [DOI: 10.1097/CCM.0b013e3181f17adf; PUBMED: 20711074] ">Marik 2010</a>; <a href="./references#CD011785-bbs2-0099" title="ShanL , LiX , LiuK , SunMN , YaoZX , LiLD . Relationship between antacid therapy and hospital acquired pneumonia in critically ill patients: a meta‐analysis. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue2013;25(6):360‐4. [DOI: 10.3760/cma.j.issn.2095‐4352.2013.06.011; PUBMED: 23739571 ] ">Shan 2013</a>). <a href="./references#CD011785-bbs2-0088" title="MarikPE , VasuT , HiraniA , PachinburavanM . Stress ulcer prophylaxis in the new millennium: a systematic review and meta‐analysis. Critical Care Medicine2010;38(11):2222‐8. [DOI: 10.1097/CCM.0b013e3181f17adf; PUBMED: 20711074] ">Marik 2010</a> reported that in those patients who were fed enterally, stress ulcer prophylaxis did not alter the risk of gastrointestinal bleeding; overall H2RAs did not increase the risk of hospital‐acquired pneumonia; however, this complication was increased in the subgroup of patients who were fed enterally. <a href="./references#CD011785-bbs2-0099" title="ShanL , LiX , LiuK , SunMN , YaoZX , LiLD . Relationship between antacid therapy and hospital acquired pneumonia in critically ill patients: a meta‐analysis. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue2013;25(6):360‐4. [DOI: 10.3760/cma.j.issn.2095‐4352.2013.06.011; PUBMED: 23739571 ] ">Shan 2013</a> reported 'inhibitor of gastric acid' medication significantly increased the incidence of hospital‐acquired pneumonia when compared with sucralfate in 11 trials; 'inhibitor of gastric acid' therapy significantly reduced the incidence of clinically significant bleeding compared with sucralfate; however, it did not lower the incidence of overt bleeding; and there was no significant difference between inhibitor of gastric acid group and sucralfate group on either ICU mortality or hospitalisation mortality in 11 studies. <a href="./references#CD011785-bbs2-0079" title="KragM , PernerA , WetterslevJ , WiseMP , BorthwickM , BendelS , et al. Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries. Acta Anaesthesiologica Scandinavica2015;59:576‐85. [DOI: 10.1111/aas.12508; PUBMED: 25880349 ] ">Krag 2015</a> performed a systematic review of 20 trials with 1971 intensive care patients randomised to stress ulcer prophylaxis. All were judged as having a high risk of bias. There was no statistically significant difference in mortality or hospital‐acquired pneumonia, but significant gastrointestinal bleeding. <a href="./references#CD011785-bbs2-0058" title="AlhazzaniW , GuyattG , AlshahraniM , DeaneAM , MarshallJC , HallR , et al. Withholding pantoprazole for stress ulcer prophylaxis in critically ill patients: a pilot randomized clinical trial and meta‐analysis. Critical Care Medicine2017;45(7):1121‐9. [DOI: 10.1097/CCM.0000000000002461; PUBMED: 28459708] ">Alhazzani 2017</a> reported a meta‐analysis of five trials including 604 patients of PPIs versus placebo in intensive care patients and found no statistically significant difference in the risk of upper gastrointestinal bleeding, infections, or mortality. </p> <p>We found no other published systematic review of inhibitor of gastric acid prophylaxis or treatment in newborn infants. We found no guidelines around the use of inhibitor of gastric acid prophylaxis or treatment in newborn infants. A literature review raised concern regarding the association between inhibitors of gastric acid used for upper gastrointestinal bleeding or gastroesophageal reflux in preterm infants and an increased incidence of necrotising enterocolitis (<a href="./references#CD011785-bbs2-0092" title="MoreK , Athalye‐JapeG , RaoS , PatoleS . Association of inhibitors of gastric acid secretion and higher incidence of necrotizing enterocolitis in preterm very low‐birth‐weight infants. American Journal of Perinatology2013;30(10):849‐56. [DOI: 10.1055/s‐0033‐1333671; PUBMED: 23359235] ">More 2013</a>). One case‐control and one prospective cohort study including 11,346 preterm infants were included. The prospective cohort study also reported a higher incidence of infection (sepsis, pneumonia, urinary tract infection) with use of inhibitors of gastric acid. Another review of the literature of treatment of children with gastro‐oesophageal reflux reported adverse effects in at least 23% of children treated with H2RAs and 34% of those treated with PPIs, mostly including headaches, diarrhoea, nausea (H2RAs and PPIs) and constipation (PPIs) (<a href="./references#CD011785-bbs2-0069" title="CohenS , Bueno de MesquitaM , MimouniFB . Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review. British Journal of Clinical Pharmacology2015;80(2):200‐8. [DOI: 10.1111/bcp.12619; PUBMED: 25752807] ">Cohen 2015</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011785-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/urn:x-wiley:14651858:media:CD011785:CD011785-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_t/tCD011785-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD011785-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/full#CD011785-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011785-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/urn:x-wiley:14651858:media:CD011785:CD011785-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_t/tCD011785-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011785-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/full#CD011785-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011785-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/urn:x-wiley:14651858:media:CD011785:CD011785-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_t/tCD011785-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011785-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/full#CD011785-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011785-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/urn:x-wiley:14651858:media:CD011785:CD011785-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_t/tCD011785-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Prevention of upper gastrointestinal bleeding, Outcome 1 All cause mortality to near term age or discharge." data-id="CD011785-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Prevention of upper gastrointestinal bleeding, Outcome 1 All cause mortality to near term age or discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/references#CD011785-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011785-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/urn:x-wiley:14651858:media:CD011785:CD011785-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_t/tCD011785-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Prevention of upper gastrointestinal bleeding, Outcome 2 Any upper gastrointestinal bleeding in infants at risk of upper gastrointestinal bleeding." data-id="CD011785-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Prevention of upper gastrointestinal bleeding, Outcome 2 Any upper gastrointestinal bleeding in infants at risk of upper gastrointestinal bleeding. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/references#CD011785-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011785-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/urn:x-wiley:14651858:media:CD011785:CD011785-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_t/tCD011785-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Prevention of upper gastrointestinal bleeding, Outcome 3 Gastric lesions detected by endoscopy and macroscopically." data-id="CD011785-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Prevention of upper gastrointestinal bleeding, Outcome 3 Gastric lesions detected by endoscopy and macroscopically. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/references#CD011785-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011785-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/urn:x-wiley:14651858:media:CD011785:CD011785-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_t/tCD011785-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Prevention of upper gastrointestinal bleeding, Outcome 4 Serious adverse reactions." data-id="CD011785-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Prevention of upper gastrointestinal bleeding, Outcome 4 Serious adverse reactions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/references#CD011785-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011785-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/urn:x-wiley:14651858:media:CD011785:CD011785-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_t/tCD011785-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Treatment of upper gastrointestinal bleeding, Outcome 1 All cause mortality to near term age or discharge." data-id="CD011785-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Treatment of upper gastrointestinal bleeding, Outcome 1 All cause mortality to near term age or discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/references#CD011785-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011785-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/urn:x-wiley:14651858:media:CD011785:CD011785-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_t/tCD011785-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Treatment of upper gastrointestinal bleeding, Outcome 2 Duration of upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding (days)." data-id="CD011785-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Treatment of upper gastrointestinal bleeding, Outcome 2 Duration of upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/references#CD011785-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011785-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/urn:x-wiley:14651858:media:CD011785:CD011785-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_t/tCD011785-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Treatment of upper gastrointestinal bleeding, Outcome 3 Continued upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding at latest time reported." data-id="CD011785-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Treatment of upper gastrointestinal bleeding, Outcome 3 Continued upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding at latest time reported. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/references#CD011785-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011785-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/urn:x-wiley:14651858:media:CD011785:CD011785-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_t/tCD011785-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Treatment of upper gastrointestinal bleeding, Outcome 4 Anaemia requiring blood transfusion." data-id="CD011785-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Treatment of upper gastrointestinal bleeding, Outcome 4 Anaemia requiring blood transfusion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/references#CD011785-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011785-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/urn:x-wiley:14651858:media:CD011785:CD011785-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_t/tCD011785-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Treatment of upper gastrointestinal bleeding, Outcome 5 Serious adverse reactions." data-id="CD011785-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Treatment of upper gastrointestinal bleeding, Outcome 5 Serious adverse reactions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/references#CD011785-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011785-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/urn:x-wiley:14651858:media:CD011785:CD011785-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_t/tCD011785-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Treatment of upper gastrointestinal bleeding: subgroup analysis higher versus lower dose inhibitor of gastric acid, Outcome 1 All cause mortality to near term age or discharge." data-id="CD011785-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Treatment of upper gastrointestinal bleeding: subgroup analysis higher versus lower dose inhibitor of gastric acid, Outcome 1 All cause mortality to near term age or discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/references#CD011785-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011785-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/urn:x-wiley:14651858:media:CD011785:CD011785-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_t/tCD011785-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Treatment of upper gastrointestinal bleeding: subgroup analysis higher versus lower dose inhibitor of gastric acid, Outcome 2 Duration of upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding (days)." data-id="CD011785-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Treatment of upper gastrointestinal bleeding: subgroup analysis higher versus lower dose inhibitor of gastric acid, Outcome 2 Duration of upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/references#CD011785-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011785-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/urn:x-wiley:14651858:media:CD011785:CD011785-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_t/tCD011785-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Treatment of upper gastrointestinal bleeding: subgroup analysis higher versus lower dose inhibitor of gastric acid, Outcome 3 Continued upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding at latest time reported." data-id="CD011785-fig-0015" src="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Treatment of upper gastrointestinal bleeding: subgroup analysis higher versus lower dose inhibitor of gastric acid, Outcome 3 Continued upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding at latest time reported. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/references#CD011785-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/media/CDSR/CD011785/image_n/nCD011785-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011785-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Prevention of upper gastrointestinal bleeding in newborn infants</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Prevention of upper gastrointestinal bleeding in newborn infants</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> newborn infants at risk of gastrointestinal bleeding<br/> <b>Settings:</b> neonatal intensive care<br/> <b>Intervention:</b> H2RA versus no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Prevention of upper gastrointestinal bleeding</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>111 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>269 per 1000</b><br/> (78 to 931) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.42</b> <br/> (0.7 to 8.38) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single small study comparing ranitidine versus no treatment.</p> <p>Quality of evidence downgraded due to risk of bias and very serious imprecision.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Any upper gastrointestinal bleeding in infants at risk of upper gastrointestinal bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>305 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>110 per 1000</b><br/> (67 to 177) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.36</b> <br/> (0.22 to 0.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>329<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All studies compared H2RA versus no treatment.</p> <p>Quality of evidence downgraded due to risk of bias.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> No study at low risk of bias.<br/> <sup>2</sup> Single small study. Very wide confidence intervals. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Prevention of upper gastrointestinal bleeding in newborn infants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/full#CD011785-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011785-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Treatment of upper gastrointestinal bleeding in newborn infants</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Treatment of upper gastrointestinal bleeding in newborn infants</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> infants with upper gastrointestinal bleeding<br/> <b>Settings:</b> neonatal intensive care<br/> <b>Intervention:</b> inhibitor of gastric acid (H2RA and PPIs) versus no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Treatment of upper gastrointestinal bleeding</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>169 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>107 per 1000</b><br/> (44 to 256) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.63</b> <br/> (0.26 to 1.51) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>131<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Both studies compared H2RA versus no treatment.</p> <p>Quality of evidence downgraded due to risk of bias and imprecision.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Duration of upper gastrointestinal bleeding (days)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1.06 lower</b><br/> (1.28 to 0.84 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>104<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 study compared PPI versus no treatment. 1 study compared H2RA versus no treatment. No significant subgroup difference. </p> <p>Quality of evidence downgraded due to risk of bias, inconsistency and imprecision.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Continued upper gastrointestinal bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>400 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>144 per 1000</b><br/> (104 to 196) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.36</b> <br/> (0.26 to 0.49) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>451<br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 studies compared PPI versus no treatment. 3 studies compared H2RA versus no treatment. No significant subgroup difference. </p> <p>Quality of evidence downgraded due to risk of bias and imprecision.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Anaemia requiring blood transfusion</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>167 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>100 per 1000</b><br/> (18 to 532) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.6</b> <br/> (0.11 to 3.19) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single small study comparing ranitidine versus no treatment.</p> <p>Quality of evidence downgraded due to risk of bias and imprecision.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> No study at low risk of bias.<br/> <sup>2</sup> Wide confidence intervals. <br/> <sup>3</sup> Moderate heterogeneity between studies. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Treatment of upper gastrointestinal bleeding in newborn infants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/full#CD011785-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011785-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Prevention of upper gastrointestinal bleeding</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All cause mortality to near term age or discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.42 [0.70, 8.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 H2RA versus no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.42 [0.70, 8.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Any upper gastrointestinal bleeding in infants at risk of upper gastrointestinal bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>329</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.22, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 H2RA versus no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>329</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.22, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Gastric lesions detected by endoscopy and macroscopically <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.28, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 H2RA versus no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.28, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious adverse reactions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>329</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 H2RA versus no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>329</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Prevention of upper gastrointestinal bleeding</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/references#CD011785-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011785-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Treatment of upper gastrointestinal bleeding</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All cause mortality to near term age or discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.26, 1.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 H2RA versus no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.26, 1.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Duration of upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.06 [‐1.28, ‐0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 PPIs versus no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.06 [‐1.28, ‐0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 H2RA versus no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.5 [‐19.55, 0.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Continued upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding at latest time reported <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>451</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.26, 0.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 PPIs versus no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.27, 0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 H2RA versus no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.17, 0.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Anaemia requiring blood transfusion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.6 [0.11, 3.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 H2RA versus no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.6 [0.11, 3.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Serious adverse reactions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>226</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 H2RA versus no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>226</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Treatment of upper gastrointestinal bleeding</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/references#CD011785-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011785-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Treatment of upper gastrointestinal bleeding: subgroup analysis higher versus lower dose inhibitor of gastric acid</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All cause mortality to near term age or discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.26, 1.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Higher dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.15, 2.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Lower dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.22, 2.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Duration of upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.06 [‐1.28, ‐0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Higher dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.06 [‐1.28, ‐0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Lower dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.5 [‐19.55, 0.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Continued upper gastrointestinal bleeding in infants with upper gastrointestinal bleeding at latest time reported <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>451</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.26, 0.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Higher dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>207</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.33, 0.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Lower dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>244</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.09, 0.42]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Treatment of upper gastrointestinal bleeding: subgroup analysis higher versus lower dose inhibitor of gastric acid</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011785.pub2/references#CD011785-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011785.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD011785-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011785-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011785-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD011785-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD011785-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011785-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011785\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011785\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011785\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011785\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011785\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011785\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011785\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011785\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011785\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011785\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011785\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011785\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011785\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011785\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011785\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011785\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011785\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011785\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=zCmos3jT&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011785.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011785.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011785.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011785.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011785.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725515450"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011785.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725515453"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011785.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e7d1ff848f4b8',t:'MTc0MDcyNTUxNS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 